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Abstract 
The exuperantia {exu) gene plays key roles in pre-localization of the bcd mRNA 
in Drosophila oocytes. The exu protein is a phosphoprotein, which is predominantly 
phosphorylated at serine and threonine residues. Recombinant exu protein can be 
specifically modified by serine or threonine kinases including cAMP-dependent kinase 
(PKA), cGMP-dependent kinase (PKG) and protein kinase C (PKC). Moreover, 
phosphorylation of exu protein is stage specific, exu protein is mainly hyper-
phosphorylated during previtellogenic stage but equally hyper-phosphorylated and hypo-
phosphorylated during the vitellogenic stage. In this study, attempts have been made to 
identify the phosphorylation sites of exu. Moreover, role of phosphorylation in 
modulating activity of exu protein was evaluated with the use of transgenic flies. Site-
directed mutagenesis was used to change five serine or threonine residues that are highly 
conserved across different species of Drosophila. In addition, these residues were also 
conserved phosphorylation sites for various kinases. Mutated exu cDNA constructs were 
used to produce exu protein variants by in vitro translation. The mutated exu proteins 
were substrates for PKA, PKC and PKG in an in vitro phosphorylation assay. However, 
the phosphorylation patterns of the mutated proteins did not show any significant 
differences from the wild type exu protein. To test the in vivo function, one of the 
mutated genome construct was introduced into Drosophila genome by P element-
mediated transformation. The result indicated that the mutant exu protein is localized 
normally in oocyte but displays a different phosphorylation pattem in testis. Hence, the 
number of ES2 progeny was examined by a male sterility test in which one ES2 male 
xiii 
transgenic fly crossed with five wild type females. The results showed that the number of 
ES2 progeny decreased about 9% (numbers of fly per cross are:- wild type: 142+22, n=16 
cross vs ES2: 131+17, n=13 cross; p<0.04). These results suggest that phosphorylation 
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CHAPTER 1 General Introduction 
1.1 Drosophila as a model for studying development 
Generally, most of us are symmetrical at least in appearance—two eyes, two ears, two 
hands, two legs and two arms, all evenly arrayed to the right and left of an axis running 
down the center of our body. However, it is essential that we are asymmetrical——the gall 
bladder and the liver are located at the right side of our body, while the heart and the 
spleen are located at the left side of our body. Moreover, some organs are themselves 
asymmetrical——the right lung has three lobes, the left only two; the stomach has a 
bagpipe shape. The importance of body and organs asymmetry is essential for our 
survival. The organs asymmetrical arrangement is to use the space inside the body more 
efficiently. The heart is an organ like ‘‘two pumps in one，，一the right pump receives 
incoming deoxygenated blood from the peripheral tissues and organs to the lungs, 
whereas the left pump receives oxygenated blood from the lungs and pumps oxygenated 
blood out to peripheral tissues and organs. 
Body asymmetry is determined by the process of growth and development fNilsselin-
Volhard, 1996). Over the last two decades, the underlying mechanisms of development 
have become clearer, mainly because modem molecular genetics has transformed 
traditional embryology. Modem genetics enable us to understand the development of an 




development, most of the cells in a multicellular organism have little morphological 
differences. Then the cells proliferate and differentiate into a complicated organism, 
having a great variety of cell types. The fate of a cell is controlled by several major 
mechanisms, namely signal transduction, cell-cell signalling and morphogenetic gradient 
(Wolpert, 1989; Nusselin-Volhard, 1996). However, there are processes and mechanisms 
which are also involved in development. Much of our knowledge has come from 
ingenious experiments being performed in simple organisms such as fruit fly and 
nematode. Drosophila has been chosen to be a laboratory animal for studying 
developmental processes and genetics because it is easy to handle and quick to breed to a 
large population, making it possible to search through many individuals for mutations. 
1.2 The formation of the body axes in Drosophila 
Drosophila has two major embryonic axes, anteroposterior axis and dorsoventral axis. 
The formation of the body axes are established by asymmetric distribution and 
localization of signals in the embryos fNusselin-Volhard et al., 1987; Ntisselin-Volhard 
and Roth, 1989; Grunert and St. Johnston, 1996). These signals called morphogens 
provide the positional information to control cell differentiation. In Drosophila, bicoid 
{bcd) mRNA and naos mRNA are localized at the anterior and posterior ends of an 
I embryo respectively as shown in Figure 1.1. They serve as morphogens to control the 
I formation of the anteroposterior axis. To direct the formation of dorsoventral axis, a 
I 






the ventral axis. Formation of the two major embryonic axes was thought to be initiated 
independently (St. Johnston and Nusslein-Volhard, 1992) but it is now considered to 
originate initially from a single signaling pathway. The signaling pathway depends on 
communication between both the germ cells and somatic cells of the egg chambers 
(reviewed by Anderson, 1995; Lehmann, 1995). Moreover, the actual formation process 
of the two major body axes is complicated and tightly regulated. 
Dorsal 
Anterior ^ ^ ^ ^ ^ ^ ^ ^ ^ w Posterior 
_^J 
bicoid mRNA Ventral \ 
nanos mRNA 
Figure 1.1 Anteroposterior axis in Drosophila embryos is formed by 
asymmetrical distribution of the morphogens. The anteroposterior axis is established 
by asymmetric distribution of bicoid mRNA and naos mRNA at the anterior end and 
posterior end in a Drosophila embryo respectively. 
^ 
During early oogenesis, an oocyte is produced by four synchronous cells divisions of a 
stem cell in the germarium with incomplete cytokinesis, in which actin-rich intercellular 
bridges or ring canals connect the posteriorly located oocyte and the remaining fifteen 
nurse cells as shown in Figure 1.2. The ring canals allow transportation of the necessities 
for development from the nurse cells to the oocyte, whereas transcription is inactive. The 
oocyte-nurse cell cluster is covered by a layer somatic follicle cells which provide an 
asymmetry to the oocyte. The oocyte in contact with the nurse cells at the anterior on one 
end and with the follicle cells at the posterior on the other end. 
A microtubule-organizing center (MTOC) located at the posterior pole of the oocyte 
extends microtubules into the nurse cells when the oocyte growts (Theurkauf et al., 1992, 
1993; reviewed by Cooley and Theurkauf, 1994; St. Johonston, 1995) (Figure 1.3). The 
transportation of RNA and protein molecules through the microtubule network from the 
nurse cells to the oocyte, presumably via minus end-directed motors. At mid-oogenesis, 
there is a reorganization of polarity of microtubules in which the posterior MTOC 
degenerates and microtubules nucleates at the anterior pole of the oocyte. The MTOC 
reorganization is a critical process for the body axis specification. The process requires a 
signal produced from the posterior follicle cells. The transforming growth factor a 
(TGFa) homologue, gurken (grk), and the epidermal growth factor receptor homologue, 
DEMop, are thought to provide the signal (Gonzalez-Reyes et al., 1995; Roth et aL, 
1995; reviewed by Lehmann, 1995; Anderson, 1995). During early stages, the grk RNA 
accumulates between the posterior pole and the oocyte nucleus. The synthesis of gurken 
protein is thought to activate the DER/TOP receptor tyrosine kinase in the follicle cells 
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Figure 1.2 Formation of developing eggs from germarium. Oogenesis begins in 
region 1，with the division of a germline stem cell (S) to produce a cystoblast (Cb) and 
regenerate a stem cell. The cystoblast then divides by four synchronous cell divisions 
(Ml-M4) with incomplete cytokinesis into a 16-cell cyst in which cells are 
interconnected with actin-rich ring canals. One of the two cells (the black ones) with four 
ring canals adopts the cell fate of oocyte and takes a posterior position within the egg 
chamber. The oocyte is developed into a mature egg in a process called oogenesis which 
can be divided into different stages (King, 1970; Mahowald and Kambysellis, 1980; 
Spardling, 1993). Mature eggs are fertilized and hatched as embryos at the end of 
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Figure 1.3 Microtubule reorganization during oogenesis. Stage 1 (Panel A). A 
microtubule organization center (MTOC) appears to localize at the anterior pole of stage 
1 oocyte near the ring canal. Stages 2-6 (Panel B). The MTOC shifts to the posterior 
pole and extends microtubules into adjacent nurse cells. Stages 7-lOA (Panel C). The 
posterior MTOC is no longer detected but high concentration of microtubules is detected 
at the anterior cortex of the oocyte. A gradient of microtubules is formed from the 
anterior end to the posterior end of the oocyte. Stage lOB-12 (Panel D). Subbcortical 
microtubule bundles assemble and ooplasmic streaming begins. The egg chambers are 









which activate the expression of posterior polar follicle markers (reviewed by Schiipbach 
and Roth, 1994) (Figure 1.4). The two posterior polar follicle cells then signal back the 
oocyte to reorganize the polarity of microtubules. The cAMP dependent kinase (PKA) in 
the oocyte is a likely candidate to receive this signal from the follicle cells. It is proposed 
that the function of PKA activation is to destabilize the posterior MTOC and revert the 
polarity of microtubules. In the PKA null mutants, failure in reorientation of the polarity 
of microtubules led to mislocalization of the matemal determinants bcd and osk RNAs 
(Lane and Kalderon, 1994; reviewed by St. Johnston, 1995; reviewed by Anderson, 1995), 
whose localization at the anterior pole and posterior pole, respectively, defines the 
anteroposterior axis (Frohnhofer and Nllsslein-Volhard, 1996, 1997; Ephrussi etaL, 1911; 
Kim-Ha et al., 1991). Therefore, the microtubules reorganization process is essential for 
determination and formation of the anteropsoterior axis. 
The microtubules reorganization is also essential for the formation of the dorsal-ventral 
polarity. The oocyte nucleus seems to be always in association with the minus end of the 
microtubule (reviewed by Cooley and Theurkauf, 1994) and moves from the posterior to 
anterior cortex ofthe oocyte during the reorganization of polarity of microtubules (Figure 
1.4) (Goonzalez-Reyes et aL, 1995; Roth et aL, 1995). The grk mRNA, which remains in 
association with the oocyte nucleus, moves together with the oocyte nucleus to the future 
anterior-dorsal comer of the oocyte and thus defines the dorsal-ventral axis (reviewed by 
Schiipbach and Roth, 1994). The mechanism was thought to involve in the synthesis of 
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Figure 1.4 A model for the initiation of estabUshment of the two body axes by 
one single signal. The gurken mRNA is associated with the nucleus which locates at the 
posterior pole of the oocyte at stages 3-6 (Panel A). Its expression induces the follicle 
cells to adopt posterior cell fates. The two posterior polar follicle cells then signals back 
to induce the reorganization of microtubules within the oocyte (Panel B). The nucleus as 
well as the gurken mRNA move along the cortex toward the anterior in response to the 
repolarization of the microtubules (Panel C). Once the nucleus reaches the anterior 
comer of the oocyte, gurken signals the overlying follicle cells to adopt dorsal cell fates. 
Thus the formation two body axes can be initiated by one single signal (Panel D). 
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dorsal follicle cells. These dorsal follicle cells take a dorsal cell fates and this in tum 
defines the ventral follicle cell fates. The dorsal-ventral polarity is formed by the 
activation of the Toll receptor in the ventral oocyte membrane through the signal 
provided from the ventral follicle cells (reviewed by Morisato and Anderson, 1995). 
1.3 Maternal genes are essential for development 
About thirty genes have been identified to produce the matemal signals fNusselin-
Volhard et al., 1987). These matemal genes can be divided into four groups due to their 
different fonctions. In the formation of anteroposterior axis, three groups are necessary, 
the anterior, posterior and terminal genes. In the formation of the dorsoventral axis, the 
dorsoventral group genes are required. 
The knowledge on the matemal genes are coming from the study of genetic screens 
designed to isolate matemal-effect mutations that affect the embryonic pattem (Gans et 
al., 1975; Schupbach and Wieschaus, 1986; Nusselin-Volhard et aL, 1987). The 
mutations in the anterior matemal genes caused loss of the anterior structures, head and 
thoraxic. The mutations in the posterior matemal genes resulted in the deletion of 
abdominal segments and structures. The terminal matemal genes mutations caused 
defects in the unsegemented ends of the embryo, the acron and the telson (Figure 1.5). 
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Figure 1.5 Embryonic pattern of maternal mutants. The matemal genes mutations 
caused the loss of corresponding body structures. For the anterior matemal mutants, head 
and thoracic structures are loss. For the posterior matemal mutants, abdominal segments 
are missed. For the terminal matemal mutants, acron and telson are deleted. (A, anterior 
structures, such as head and thoracic segments; P，posterior structures, abdominal 
segments; T, terminal structures, acron and telson; Ac, acron; He, head; Th, thorax; Ab, 






Several mutations, bicoid {bcd), exuperantia (exu), swallow (5*mv), staufen {stau), 
bicaudal {hic), Bicaudal-D {BicD) and Bicaudal-C {BicC) (Frohnhofer and Nusselin-
Volhard, 1986, 1987; Schupbach and Wieschaus, 1986; Gans et al., 1975; reviewed by 
Niisselin-Volhard et al,, 1987; Macdonald, 1992) are responsible for the anterior defects. 
Meanwhile, several mutations, inculding oskar {osk), vasa {vas), tudor (tud), staufen 
{stau), valois (yaP), nanos {nos) and pumilio (j)um) (Lehmann and Nusselin-Volhard, 
1986; Schtipbach and Wieschaus, 1986; Boswell and Mahowald, 1985; reviewed by 
Nusselin-Volhard et al., 1987) affect the posterior structures formation. For the terminal 
structures, several mutations, toros {tor), trunk {trk), torsolike {tsP),fs(I) polehole [fs(l)ph 
and fs(l) Nasrat \fs(l) N\ (Schupbach and Wieschaus, 1986; Perrimon et aL, 1986; 
Degelmann et al., 1986; reviewed by Nusselin-Volhard et al., 1987) control the formation 
of terminal structures. 
1.4 Maternal gene bicoid is essential for formation of anterior 
structures in the embryo 
In the bcd null mutants, the embryo anterior structures (head and thorax) are lost and the 
posterior structure (telson) is duplicated (Figure 1.6) (Frohnhofer and Nusselin-Volhard, 
1986). In the cytoplasmic transplantation experiments (reviewed by St. Johnston and 
Nusselin-Volhard, 1992), the anterior pole of the wild type embryo was transplanted to 
the same region of the bcd null mutant embryo. The bcd phenotypes in the bcd mutants 
I were restored by the transplantation of anterior pole from the wild type embryos 
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Figure 1.6 Developmental defects in the maternal gene mutants. In bicoid 
mutants, the anterior structures (head and thorax) are lost and the anterior acron is 
transformed into a telson. In oskar mutants, abdominal segments are lost while the acron 
and telson are missing in the torso mutants. The hatched rectangles in the upper row 
indicated that the normal origin of the regions that are deleted. The second row shows 
the corresponding changes in the fate maps of the embryo while the lower rows shows 
the cuticle defects of the larvae. (Ac, acron; Th, Thorax; He, head; Ab, abdomen; Te, 
telson) (Originally published in Nusselin-Volhard et al., 1987). 
12 
(Frohnhofer and Niisselin-Volhard, 1986, 1987). It is suggested that bcd is essential for 
formation of the anterior structures. � 
1.5 The formation of bicoid protein gradient from anterior pole to 
posterior pole of the embryo 
The matemal gene bcd controls anterior structures formation and development in 
Drosophila embryo. The bcd mRNA is localized at the anterior pole of the oocyte and 
early embryo (Driever and Ntisselin-Volhard, 1988a). The localized bcd mRNA is 
translated to produce an anterior to posterior concentration gradient of bicoid protein, 
which extends over anterior two-thirds of the embryo (Figure 1.7) (Frigerio et al., 1986; 
Berleth et al., 1988; Driever and Niisselin-Volhard, 1988b; St. Johnston et al., 1988). 
The bicoid protein gradient controls the formation of anterior structures (head and thorax) 
in a concentration-dependent manner (Driever and Ntisselin-Volhard, 1988b). 
The bicoid protein is distributed in an exponential concentration gradient. The gradient is 
generated by translation of and diffusion of bcioid protein from the local bcd mRNA 
source and dispersed degradation of the bicoid protein throughout the embryo (Driever 
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Figure 1.7 The bcd protein gradient and the expression pattern of hunchback 
{hb). The bcd protein gradient is produced by translation ofthe localized ^c^/mRNA at 
the anterior pole of embryo. The hb protein is homogenously distributed at the anterior 
half of the embryo. The expression of hb mRNA is activated by bcd protein at the 




1.6 The bcd protein gradient controls the downstream zygotic target 
genes in a concentration-dependent manner 
The bcd protein gradient has been established in the embryo. The bcd protein serves as a 
transcriptional activators and the protein regulates the expression of downstream zygotic 
target genes. The group of zygotic genes known as gap genes whose mutations result in 
elimination of particular regions of the embryo and create gap in the anteroposterior 
pattem (Ingham, 1998; reviewed by Lawrence and Struhl, 1996). In the anterior part of 
the embryo, bcd protein activates the transcription of hb. Then the bcd protein binds 
cooperatively with hb protein to several target genes, such as orthodentical, giant and 
hunhback itself, as a result the target genes are activated in specific regions and the 
embryo was subdivided into several regions (reviewed by Lawrence and Struhl, 1996). 
The spatial gene products contain DNA binding domains and serve as transcriptional 
regulators. The transcriptional regulators regulate the downstream segmentation genes to 
subdivide the body into different segments and regions (Tautz et al., 1987; reviewed by 
Struhl et aL, 1989; reviewed by Lawrence and Struhl, 1996) (Figure 1.8). The gap genes 
control the expression of the pair-rule genes (for example engrailed and wingless). The 
pair-rule genes control the formation of the parasegment boarders in the embryo. The 
gene products of pair-rule genes activate the expression of the segment polarity genes 
which is controlling the formation of the polarity in each segment of the trunk. The 
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Figure 1.8 Formation of body polarity. The polarity is originated from the matemal 
effect genes and then the expression of the gap genes. The gap genes divide the body 
into several segments as well as control the expression of pair-rule genes. The pair-rule 
genes control the expression of the segment polarity genes and the genes products 
determine the polarity in each segment. (Originally published in Gilbert, 1994) 
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the formation the segment of the embryo (Figure 1.9). The homeotic genes fUrther 
specify and direct the development of different parts in segment (Ingham, 1998; reviewed 
by Lawrence and Struhl, 1996) thus the cell fates can be precisely defined along the 
anteroposterior axis of the embryo. 
1.7 The formation of bcd protein gradient in embryo 
The bcd mRNA is localized to the anterior end before this gradient formation. The 
localization of bcd mRNA at the anterior end begins at oogenesis and the localization can 
be divided into at least four separable steps (St. Johnston et aL, 1989; reviewed by Lasko, 
1999) (Figure 1.10). The bcd mRNA begins to accumulate in stages 4-6 of oogenesis in a 
ring in the posterior cytoplasm of the oocyte. The posterior ring is shifted to the anterior 
pole of the oocyte during stages 7 and 8 through two redundant RNA-protein interaction 
events (Macdonald and Kerr, 1997). In the stage 9 of oogenesis, an abundant of bcd 
mRNA is synthesized in the nurse cells. The bcd mRNA accumulates and concentrates 
with variable intensity in patches adjacent on the apical side to the nurse cell nuclei (St. 
Johnston et al., 1989; Macdonald et al., 1995). In stage 10 of oogenesis, the bcd mRNA 
is transferred from the nurse cells to the oocyte along with the nurse cell cytoplasm. In 
the late stages of oogenesis, the bcd mRNA is redistributed from across the entire anterior 
of the oocyte to a spherical distribution centered on the dorsal-anterior comer. 
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Figure 1.9 Interaction between the pair-rule genes and the segment polarity 
genes in segmentation. (A) Expression of polarity gene engrfailed {en) and wingless 
(wg) is initiated by pair-rule genes fushi tarazu (ftz) and even-skipped {eve). The 
expression of en is found in cells transcribe the gene product of either/te or eve. In 
constrast, expression of wg is found in cells that contain neither ftz nor eve, but a third 
gene odd-paired {opa) is present. (B) Expression of en and wg is maintained by the 
interactions of engrailed and wingless protiens. Wingless protein is synthesized in wg 
expressing cells and diffuses out to the surrounding cells. In cells that contain high 
concentration of ftz or eve (en competent), the autoinduction of engrailed protein 
expression is inhibited by zeste-white-3 (zw3) protein, of which inhibitory effect is 
released by the presence ofhigh concentration of wingless protein. In cells that express 
high concentration ofengrailed protein, hedgehog (hh) protein is synthesized and diffuse 
to the surrounding cells. Hedgehog protein binds to patched protein that is expressed in 
the cell surface ofwg-competent cells. The binding ofhh to patched protein released the 
inhibition of wg expression by patched protein. As a result, the expression of wingless 
and engrailed portein is mutually stabilized. 
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Figure 1.10 Four major phases of bcd mRNA localization during oogenesis. 
The four phases of localization can be disrupted in several matemal mutants, exu, 5ww 
and stau and thus the three genes are involved in localization of bcd mRNA in a stepwise 
manner. The numbers below each egg chamber refer to the stages of oogenesis. Nurse 
cells (nc), follicle cells (fc), oocyte (oo). (Originally published in Lasko, 1999) 
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1.8 Components jequired for bcd mRNA localization at anterior 
pole of oocyte 
1.8.1 C/s-acting elements 
The bcd mRNA localization process is a complicated and tightly regulated process. 
Therefore, bcd mRNA localization depends on several elements. In an exhaustive 
deletion analysis, a 53 nucleotide region of the bcd 3，untranslated region (BLE1) was 
identified (Macdonald and Struhl, 1988). The BLE1 ofbcd 3，UTR deletion mutant fail 
to rescue the bcd null phenotype, producing completely inviable embryos (Macdonald et 
al., 1993). It is suggested that BLE1 is essential for the bcd mRNA localization at the 
anterior pole of oocyte. But BLE1 is unable to maintain the bcd mRNA at the anterior 
pole beyond stage 9 of oogenesis (Macdonald et al., 1993). It is suggested that the other 
elements are required to maintain the bcd mRNA localization beyond stage 9 of 
oogenesis. 
1.8.2 Trans-acting elements 
The bcd mRNA localization depends on a number of czi'-acting elements and trans-diQimg 
factors. Three genes that are necessary for localization of the bcd mRNA have been 
identified, exuperantia {exu), swallow (^ww) and staufen {stau) (Gans et al., 1975; 
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Schilpbach and Nusselin-Volhard, 1987; Stephenson et al., 1988; St. Johnston et al., 
1989). Mutations of these three genes resulted in the loss of anterior structures (head and 
thorax) (Figure 1.11). The bcd mRNA localization in these mutants were also defective 
(Figure 1.12). 
The bcd mRNA localization is a multi-step process. These three genes control the bcd 
mRNA localization at different developmental stages. The earliest factor controls the 
mRNA localization is exuperantia (St. Johnston et al., 1989). In the exu null mutants, the 
initial localization of bcd mRNA during stages 5 - 7 of oogenesis is normal. From stages 
8-9 of oogenesis, bcd mRNA still localized at the anterior pole but the mRNA are more 
diffused as opposed to the tight localization as seen in the wild type. In the stage 10 of 
oogenesis, bcd mRNA is localized neither at the anterior nor the apical region of the 
nurse cells in the exu null mutants. 
In sww mutants, bcd mRNA localization is still normal up to stage 10a of oogenesis. At 
stages 10b and 11 of oogenesis, bcd mRNA is not tightly localized at the anterior pole. 
By stage 12 of oogenesis, all bcd mRNA is released from the cortex and form a shallow 
anterior to posterior gradient. 
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Figure 1.11 Cuticle patterns of maternal gene mutants showing loss ofthe anterior 
pattern in larvae. In Panel A, a wild type larva; panel B，a bccF mutant larva, a strong 
bcd allele; panel C，a exu mutant larva; panel D, a ^mv mutant larva and panel E, a stau 
mutant larva. In bccf^ mutants, the anterior structures (head and thorax) are replaced by a 
duplicated telson and the anterior abdomen is defective. In exu and sww mutants, the 
head structure is loss. In stau mutants, the anterior structure is totally defected. 
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Figure 1.12 Localization of bcd mRNA in the oocyte and the egg of wild type and 
various maternal gene mutants. In the three mutants, exu, sww and stau, bcdmRNA is 
not tightly localized at the anterior pole of the oocyte. The exu mutants display the 
earliest defects in the localization and result in loss of the anterior localization in the 
oocyte and the apical localization in the nurse cells. (Originally published in Lawrence, 
1992) 
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In stau mutants, bcd mRNA localization is still normal up to stage 12 of oogenesis. After 
stage 12, all bcd mRNA is released from the cortex of embryo. The bcd mRNA localized 
in the early embryo. All the mutations of these three genes cause the mislocalization of 
bcd mRNA as which results in the loss of anterior structures in the mutants. 
1.9 The properties of exu protein 
1.9.1 The function of exu protein 
The formation of the anteroposterior bicoid protein gradient in Drosophila occurs as a 
result of the prelocation of bicoid mRNA at the anterior end of the oocyte (Berleth et al., 
1988a; Driever and Nusslein-Volhard, 1988a; Driever and Nusslein-Volhard, 1988b; 
Frigerio et al., 1986; St. Johnston et al., 1989). The localization of bicoid mRNA at the 
anterior end requires the expression of at least three genes, they are exu, sww and stau 
(Frohnhofer and Nusslein-Volhard, 1987; St. Johnston et al., 1989; Stephenson et aL, 
1988). The exuperantia gene acts the earliest in the pathway. The exuperantia protein is 
colocalized at the apical regions of the nurse cells with bicoid mRNA at specific 
developmental stages during oogenesis. This shows the functional relationships between 
exuperantia protein and bicoid mRNA. However at later stages, bicoid mRNA is not 
colocalized with exuperantia protein when the bicoid mRNA is translocated to the 
anterior end of the oocyte from the nurse cells (Macdonald et al., 1991). 
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1.9.2 Exuperantia protein is a phoshoprotein 
Exuperantia encodes a protein of 532 amino acids with a predicated a molecular mass of 
57981 daltons. The predicted protein sequence has neither homology to any 
characterized gene nor known common functional motifs (Macdonald et al., 1991; 
Marcey et al., 1991). Multiple forms of exu protein were observed by Westem blotting. 
In the northem blot analysis, exuperantia protein was shown to exist in only one isoform 
which eliminated the possibility that mutiform of exu protein were formed by alternative 
RNA splicing. Therefore, it is suggested that exuperantia protein is posttranslationally 
modified (Macdonald et al., 1991). A number of the biological functions and 
physiological characteristics of a protein can be attributed to their posttranslational 
modifications including acetylation, methylation, glycosylation, sulfation, ribosylation， 
prenylation and phosphorylation. 
The exuperantia protein is not likely to be modified by glycosylation because most 
glycoproteins are either secretary proteins or cell-surface proteins, whereas exu protein is 
a cytoplasmic protein. Furthermore, glycoprotein resolved by SDS-PAGE often appears 
as a smear, which was not the case for exu protein. If exu protein was really 
posttranslationally modified by phosphorylation, the multiple isoforms of exuperantia 
protein might represent different phosphorylated forms. 
Previous results (Cheung, 1997) showed that exu protein was posttranslational modified 




(unpublished data). It has been demonstrated that exu protein was metabolically by direct 
injection of [^^P]orthophosphate into Drosophila. The [^^P]-labeled exu protein was 
evidenced by immunoprecipitation with a rabbit polyclonal anti-exu antibody. Thus, it is 
suggested that exu protein is modified by posttranslational phosphorylation. 
In dephosphorylation experiment, endogenous exu was dephosphorylated by three 
different types of phosphatase (Cheung, 1997). The endogenous exu protein was non-
specifically dephosphorylated by calf intensine phosphatase (CIP) which removes 
phosphate group on the serine, threonine and tyrosine residues. The endogenous exu 
protein was also dephosphorylated by the serine-theronine specific-- protein phosphatase 
I. However, the tyrosine specific phosphatase, T-cell phosphotyrosine phosphatase, 
cannot removed the phosphate group on exu protein. Moreover, endogenous exu protein 
cannot be recognized by aphospho-tyrosine antibody. Therefore, it is suggested that exu 
protein is phosphorylated on serine and threonine amino acid residues predominantly. 
Recombinant exu protein can serve as a substrate in vitro of three serine/threonine 
specific protein kinases: cAMP dependent protein kinase (PKA), protein kinase C (PKC) 
and cGMP dependent protein kinase (PKG) (Cheung, 1997). The phosphorylation 
reactions on the endogenous exu protein were inhibited by incubating the endogenous 
exu protein in PKA, PKC and PKG specific inhibitors: H89, staurosporine and KT5926, 
respectively (Cheung, 1997). However, the other four serine/threonine kinases, CKI, 
CKII, GSK-3 and p34^ ^^ ^ were unable to phosphorylate the exu protein in an in vitro 
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phosphorylation assay. These results confirmed that native exu protein is a 
serine/threonine-predominant phosphoprotein. 
1.9.3 Phosphorylation pattern of exuperantia is stage-specific 
The phosphorylation pattem of exu protein is stage-specific (Cheung, 1997). In the 
previtellogenic stages (stages 1 to 6), exu proteins were mainly present in 
hyperphosphorylated forms whereas those in vitellogenic stages (stages 7 to 10) exist in 
equal amounts of hyperphosphorylated and hypophosphorylated form. After the 
vitellogenic stages (stages 11 to 13)，no exu protein was detected by Westem blot 
analysis. 
The stage-specific phosphorylation pattem of exuperantia protein gives insight into 
relationships between the exu protein phosphorylation and the colocalization pattem 
between exu protein and bcd mRNA. In different developmental stages, the 
hyperphosphorylated and hypophosphorylated forms of exuperantia protein may have 
different interactions with bcd mRNA andA)r the other component(s) as well as 
ribonucleoprotein (RNP) particles. These may control the localization of bcd mRNA in 
different developmental stages. Moreover, the phosphorylation patterns of exu are 
different in ovary and testis extracts (Cheung, 1997). The exu protein in testis consists of 
phosphorylated isoforms with higher molecular weight than those in the ovaries. It was 
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complicated than exu protein in ovary, involving different kinases systems and additional 
phosphorylation sites. 
1.9.4 Reversible phosphorylation is one of the major mechanisms to 
control protein activity in all eukaryotic cells 
Protein phosphorylation and dephosphorylation have been implicated in different cellular 
events, including the regulation of numerous intracellular processes, cellular response to 
extracellular signals such as hormones and growth factors, as well as the timing of 
cellular events such as DNA synthesis and mitosis which must occur at defined stages in 
the cell cycle (Hardie, 1993). 
The Drosophila homeodomain-containing protein Fushi tarazu (Ftz) is a good example 
which illustrates the importance of phosphorylation in Drosophila development. The 
function of Fushi tarazu is thought to control the expression of the segment polarity gene 
engrailed then the formation of segments in Drosophila. To show the importance of 
phosphorylation on Fushi tarazu, the phosphorylated residue T263 of Fushi tarazu protein 
was changed to alanine T263A by site-directed mutagenesis (Dong et al., 1998). In the 
T263 mutant of fushi tarazu, the expression of engrailed in Drosophila embryo was 
changed such that fushi tarazu-dependent engrailed stripes were partially missing. 







The Drosophila segment polarity gene engrailed (en) is another good example that 
illustrates the importance of phosphorylation. Engrailed protein is a phosphoprotein with 
sequence-specific DNA-binding activity (Gay et al., 1988). Engrailed protein is also a 
transcriptional regulator which controls the expression of hedgehog expression in the 
posterior compartment cells in the wing imaginal disc (Sanicola et aL, 1995). The DNA 
binding activity of engrailed protein was modified by phosphorylation. In a recombinant 
engrailed protein which carries an extended version of homodomian (En-374/552) the 
sequence-specific DNA-binding capacity was enhanced by casein kinase II-dependent 
phosphorylation (Bourbon et al” 1995). In contrast, the casein kinase II-dependent 
phosphorylation on a truncated version of engrailed protein only increased the protein 
DNA-binding activity slightly (Bourbon et al., 1995). 
1.9.5 The relationship between exu protein phosphorylation and bcd 
mRNA localization 
The bcd mRNA localization at the anterior end of Drosophila oocyte is essential for 
anteroposterior axis establishment, the molecular mechanism that control the polarization 
ofoocyte cytoplasm is still unclear. 
The exu is known to be the first factor which controls the localization of bcd mRNA at 
the anterior pole of oocyte. Exu protein is localized with bcd mRNA at the apical regions 
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of nurse cells at specific stages during oogenesis, and mis-localization of bcd mRNA 
have been observed in the exu null mutants. This result suggests that exu is related to the 
bcd mRNA localization during oogenesis. In the PKA null mutants, the bcd mRNA 
failed to localize, the localization and phosphorylation of exu protein were changed. It is 
suggested that PKA controls the localization of bcd mRNA through exu protein. 
In order to understand the molecular mechanism behind the formation of the 
anteroposterior axis, one of the crucial issues that need to be addressed is to find out the 
ftinction(s) and the role(s) of phosphorylation on exu protein during oogenesis. 
1.10 Aim of project 
Since the biological function(s) of phosphorylation on exu proetin are still unclear. The 
role of phosphorylation on exu protein and the specific amino acids residues of exu 
protein involved in phosphorylation need to be identified. Therefore, attempt has been 
made to remove the potential phosphorylation sites of exu protein by in vitro site-directed 
mutagenesis. The genomic DNA and complementary DNA constructs of exu were 
generated. Moreover, exu protein is tagged with human c-myc epitope in order to 
distinguish the endogenous and exogenous exu protein. 
Recombinant exu protein variants have been generated by an in vitro transcription and 
translation coupling system. The phosphorylation patterns of the exu protein variants 
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were studied by in vitro phosphorylation assay. Meanwhile, an exu genomic mutant 
construct was subcloned into a Drosophila transforming vector (pCasPeR) with the 5，and 
3’ untranslated region of exu genomic DNA sequence (pCl). The mutant constructs have 
been introduced into the germline of Drosophila by P-element mediated transformation. 




CHAPTER 2 Preparation of the exuperantia genomic DNA and 
complementary DNA (cDNA) mutant constructs 
2.1 Introduction 
Exuperantia protein controls the localization of bcd mRNA at the anterior end of oocyte 
and the formation bicoid protein gradient along Drosophila embryos. How exu protein 
regulates bicoid mRNA localization is still unknown. 
Protein phosphorylation is an important switch that converts cellular activity from one 
state to another one. Indeed, phosphorylation of protein is a major mechanism of cell 
responding to extracellular signals such as hormones and growth factors. Moreover, 
protein phosphorylation is responsible for the timing of events which must occur at 
defined stages in the cell cycle, such as DNA synthesis and mitosis. 
Phosphorylation and localization of exu protein are stages specific. The phosphorylation 
pattem of exu protein in previtellogenic stage and vitellogenic stage are different and 
stages specific. The distributions and localizations of exu protein depend on the stages of 
the oocyte. In contrast to a hyperphosphorylated form in wild type, hypophsophorylated 
form of exu protein from cAMP-dependent kinase (PKA) deficient mutant {DCO^ )^ was 
predominant in both previtellogenic and vitellogenic stages (Cheung, 1997). Different 
phosphorylation patterns of exu protein were observed in mutants deficient in 
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endogenous cAMP dependent kinase (PKA). Moreover, localization of exuperantia 
protein was clearly altered in the PKA mutants from stage 7 onward. The changes in 
phosphorylation pattem and localization pattem of exuperantia protein in PKA mutants 
suggest a functional relationship between exu protein phsophorylation and localization. 
It is believed that phosphorylation on exuperantia protein is one of possible mechanisms 
that controls the biological function of exu protein. 
The aim of my research is to investigate the role of phosphorylation on exu protein. 
Effort was made to identify the phosphorylation residue(s) of exu protein. The strategy 
of my research is to remove the potential phosphorylation site(s) on exuperantia protein 
systematically by in vitro site-directed mutagenesis. A set of exu genomic DNA and 
cDNA mutant constructs were created. The genomic DNA construct was used to produce 
transgenic flies by P-element mediated transformation. The exu protein phsophorylation 
pattem and localization of the exu transgenic flies were studied. The exu cDNA 
constructs were used to produce mutated exuperantia protein by an in vitro transcription 
and translation coupling system. The in vitro translated exu protein was examined by in 
vitro phosphorylation with PKA, PKC and PKG. 
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2.2 Materials and Methods 
2.2.1 DNA preparation methods 
2.2.1.1 Preparation of double-stranded plasmid DNA by 
polyethylene glycol 6000 
Single colony containing the interested plasmid from a LB plate with the corresponding 
antibiotic was picked into 2ml LB medium in a 15ml snap tube. The cells were incubated 
at 2>TC ovemight with shaking at 225 rpm. The ovemight culture (lml) was transferred 
into 100ml LB medium in a 500ml flask and incubated at 37°C ovemight with shaking at 
225 rpm. The cells were pelletted by centrifUgation at 5000rpm for 5 minutes at 4°C in a 
JA 14 rotor in Beckman J-2 MC centrifuge. The supernatant was discarded and the pellet 
was gently resuspended in 1.2ml Solution I (40g glucose, 100ml lM Tris-HCl, pH 8.0, 
80ml 0.5M EDTA, make up to 4L with double-distilled water) and incubated on ice for 5 
minutes. The cells were lysed with 2.4ml freshly prepared Solution II (0.2ml 10N 
sodium hydroxide, 0.5ml 20% SDS and make up to 10ml with double-distilled water), the 
cells were mixed gently by inversion and then the cells were incubated on ice for 5 to 10 
minutes. The cells were added with 2.0ml Solution III (1000g potassium acetate, 600ml 
glacial acetic acid and make up to 4L with double-distilled water) and the cells were 
incubated on ice for 5 to 10 minutes. The debris was pelletted by centrifugation at 
10000rpm at 4�C for 30 minutes in a JA 20 rotor in Beckman J-2 MC centrifuge. The 
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DNA supernatant was transferred into a 15ml snap tube. The RNA in the DNA 
supernatant was digested with 30^il of 2mgAnl RNAase at 37°C for 30 minutes. The 
proteins in the DNA supernatant were extracted by phenoL^chloroform extraction. Equal 
volume of phenoVchloroform solution was added to the DNA solution. The 
phenol/chloroform and aqueous phase were separated by centrifugation at 3500rpm at 
25°C for 5 minutes in a JA 5.2 rotor in Beckman J-6MyTE centrifuge. The upper aqueous 
layer was transferred into a new 15ml snap tube. The phenol in the upper aqueous layer 
was extracted with equal volume of chloroform by gentle mixing. The chloroform was 
separated with the aqueous phase by centrifugation at 3500rpm at 25°C for 5 minutes in a 
JA 5.2 rotor in Beckman J-6My^ centrifuge. The upper aqueous layer was transferred 
into a new 15ml snap tube. The DNA was precipitated by 0.6 volume of isopropanol at 
room temperature for 30 minutes. The DNA was pelletted by centrifugation at 10000rpm 
at 25°C for 15 minutes in a JA 20 rotor in Beckman J-2 MC centrifuge. The supernatant 
was discarded and the DNA pellet was resuspended in 0.4ml TE. The DNA was re-
pelletted by 85^il of 5M sodium chloride and 0.5ml of 13% polyethylene glycol 6000 on 
ice for 60 minutes. The DNA was pelletted by centrifugation at 13000 rpm for 15 
minutes in a table-top centrifuge. The supematant was discarded and the DNA pellet was 
washed with 1ml 70% ethanoL The DNA pellet was air-dired and resuspended in 100|il 
ofTE. 
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2.2.1.2 Preparation of M13mp8 single-stranded DNA 
Single colony of TG1 E. coli cells on a glucose/minimal medium plate was picked into 
10ml 2X TY medium and the cells were incubated at 3TC ovemight with shaking at 225 
rpm. The ovemight culture (50^1) was inoculated into 5ml 2X TY medium in a 50ml 
flask and the cells were incubated at 37°C with shaking at 225 rpm till O.D.600nm =0.3. 
The diluted culture (lOO i^l) was inoculated with a single recombinant plaque and 
incubated at 37°C for 5 hours with shaking at 225 rpm. The culture was transferred into 
five micro-centrifuge tubes. The cells were collected by centrifugation at 13000 rpm in a 
table-top centrifuge for 5 minutes. The supernatant was transferred into a new micro-
centrifuge tube. The supernatant was re-spin at 13000 rpm for 5minutes in order to 
remove the TG1 cells and double-stranded DNA contamination. The M13 bacteriophages 
(lml) in the supernatant were precipitated with 200^il of PEG/^aCl solution (20g 
polyethylene glycol 6000，14.6g sodium chloride, make up to 100ml with double-distilled 
water and. sterilized by autoclaving) at room temperature for 15 minutes. The 
bacteriophages were pelletted by centrifugation at 13000 rpm for 5 minutes. The 
supernatant was removed. The bacteriophage-pellet was re-spin at 13000 rpm for 2 
minutes to remove trace of PEG/NaCl solution. The bacteriophage pellet was 
resuspended inlOO i^l TE by vortex for 30 seconds. The protein coat of the bacteriophage 
was removed by phenoVchloroform extraction. The bacteriophage solution was added 
with 50p,l of phenoVchloroform and then vortex for 20 seconds. The solution was stand 
at room temperature for 14 minutes and then vortex for 20 seconds. The solution was 
spin at 13000 rpm for 3 minutes to separate the upper aqueous DNA phase with lower 
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organic phenol/chloroform phase. The upper aqueous phase was transferred to a new 
micro-centrifuge tube. In order to remove the trace phenoVchloroform in the aqueous 
phase, equal volume of chloroform was added into the aqueous phase and vortex for 20 
seconds. The aqueous phase was separated with chloroform by centrifugation at 13000 
rpm for 3 minutes. The aqueous phase was transferred to a new micro-centrifoge tube. 
The single-stranded DNA was precipitated by 0.1 volumes of 3M sodium acetate, pH 5.2 
and 2 volume of absolute ethanol at —70�C for 60 minutes. The single-stranded DNA was 
collected by centrifugation at 13000rpm for 15 minutes and then washed with 1ml 70% 
ethanol. The DNA pellet was air-dired and resuspended in 100pi ofTE. 
2.2.1.3 Preparation of double-strand DNA by Biol prep (modified 
from Maniatis etal., 1989) 
Single colony containing the interested plasmid from a LB plate with the corresponding 
antibiotic was picked into 2ml LB medium in a 15ml snap tube. The cells (lml) were 
incubated at 37�C ovemight with shaking at 225 rpm. The cells were transferred into a 
1.5ml micro-centrigufuge tube and collected by centrifugation. The cells were 
centrifugated at 10000rpm for 2 minutes in a table-top microcentrifuge. The 
supemantant was discarded. The bacterial cells pellet was resusupended with 400^il of 
Biol Prep solution (8% sucrose, 0.5% trition X-100, 50mM EDTA, 60mM Tris-HCl, pH 
7.5) with a pinch of lysozyme by pipetting up and down. The cells were boiled in a 
boiling water bath for 40 seconds. The cells were centrifuged at 1300rpm for 15 minutes. 
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The protein debris was removed with a toothpick. The DNA was precipitated by the 
addiation of 400^il of isopropanol at room temperature for 5 minutes. The DNA was 
collected by centrifugation at 13000rpm for 15 minutes and the supemantant removed. 
The DNA pellet was washed twice with 1ml 70% ethanol. The DNA pellect was 
resuspended in 35^il ofTE with lO^g/ml RNase. 
2.2.2 Transformation of DH5a, JM109 or TG1 competent cells 
Single colony of JM109, TG1 or DH5a E. coli cells was picked into 2ml LB medium in a 
snap cap tube. The cells were incubated at 37�C ovemight with shaking at 225 rpm. The 
ovemight culture (lml) was inoculated into 100ml ofPsi broth (5g bacto yeast extract, 
20g bacto tryptone, 5g magnesium sulfate, make up to lL with double-distilled water, 
adjust to pH 7.6 using potassium hydroxide and sterilized by autoclaving) at 37�C until 
O.D.500=0.48. The cells were incubated on ice for 15 minutes. The cells were collected 
by centrifugation at 5000rpm for 5 minutes at 4°C in a JA 14 rotor in Beckman J-2 MC 
centrifuge. The supematant was discarded and the pellet was gently resuspended in 40ml 
of TfbI buffer (0.588g potassium acetate, 2.42g rubidium chloride, 0.294g calcium 
chloride, 30ml glycerol, make up to 200ml with double-distilled water, adjust to pH 5.8 
with dilute acetic acid and sterile by filtration). And the cells were incubated on ice for 
15 minutes. The cells were re-collected by centrifugation at 5000 rpm for 5 minutes at 
4�C. The supematant was discarded and the pellet was gently resuspended in TfbII buffer 
(0.21g MOPS, l . lg calcium chloride, 0.121g rubidium chloride, 15ml glycerol, make up 
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to 100ml with double-distilled waster, adjust to pH 6.5 with diluted sodium hydroxide 
and sterile by filtration) and incubated on ice for 15 minutes. The competent cells were 
used immediately or quick freeze in ethanol-dry ice bath or liquid nitrogen for storage 
at-70^C. 
2.2.3 Bacteria transformation 
Frozen competent cells (DH5a, JM109 or TG1) were thrawed on ice for 5 minutes and 
100^1 of the competent cells were transferred into a sterile 15ml snap cap tube. DNA or 
ligation mixture was added into the competent cells and mix the cells gently. The cells 
were incubated on ice for 30 minutes. The competent cells were heat-shock at 2>TC for 5 
minutes. The heat-shocked competent cells were incubated on ice for 5 minutes before 
plating on agar plates. The cells were spread over the surface of the agar plate by a 
sterile bent glass and incubated at 37°C ovemight. 
2.2.4 Restriction enzyme digestion 
For restriction fragment length polymorphism, 10^1 of digestion mixture, 350ng of the 
DNA was digested with 5-10 units of restriction enzyme(s) in an appropriate digestion 
buffer at appropriate temperature for 1.5-2 hours. 
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For DNA fragment preparation, 40^il of the digestion mixture, 2^ig of the DNA was 
digested with 10-20 units of restriction enzyme(s) in appropriate digestion buffer at 
appropriate temperature for 2.5-3 hours. 
For the incompatible buffer system in the double or triple restriction enzyme digestion, 
the DNA was digested with an enzyme and then purified by phenoVchloroform extraction. 
The extracted DNA was then digested with the other restriction enzymes. 
2.2.5 Phenol/chloroform extraction 
Protein and some impurities in the DNA were removed by the phenoVchloroform 
extraction. Equal volume of phenoVchloroform was added into the DNA mixture and 
vortex the mixture for 1-2 minutes. The phenoVchloroform and the DNA separated by 
centrifugation at 4500xg for 5 minutes. The DNA presented in the upper aqueous phase 
which was transferred to a new tube. Equal volume of chloroform was added into the 
aqueous phase and vortex for 1-2 minutes. The function of the chloroform extraction is 
to remove phenoL^chloroform contamination in the aqueous phase as phenol 
contamination in the DNA affected enzymatic reaction. The chloroform and the aqueous 
phase were separated by centrifugation at 4500xg for 5 minutes. The upper aqueous 
phase was transferred to a new tube. The DNA in the aqueous was precipitated by 0.1 
volume of sodium acetate, pH 5.2 and 2 volumes of absolute ethanol and mixed by gentle 
inversion. The DNA was precipitated at -70�C for 30 minutes or -20°C for 2-3 hours. 
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The DNA was collected by centrifugation at 10000xg for 15 minutes and the DNA pellet 
was washed with 70% ethanol in order to remove salts. Finally, the DNA pellet was 
resuspended in TE. 
2.2.6 Purification of DNA fragment by electro-elution 
Plasmid DNA (2|ig) was digested with appropriate restriction enzymes. The DNA 
fragments were separated by agarose gel electrophoresis that contained 0.5p,g/ml of 
ethidium bromide. The slice of agarose gel containing the band of interest was cut out 
with a sharp blade. One end of a piece of dialysis tubing was sealed with a dialysis clip. 
The tubing was filled with 1 X TBE. The band of interest was transferred into buffer-
filled dialysis tubing by a forceps. The volume ofbuffer in the tubing was adjusted to be 
enough to keep the gel slice in constant contact with the buffer. Air bubbles in the tubing 
were removed. Then the other end of the dialysis tubing was sealed. Electro-dialysis 
was carried out at a constant voltage of 100V for about 45 minutes. After that, polarity of 
the current was reversed for 30 seconds in order to release the DNA from the inner wall 
ofthe tubing. The buffer in the tubing was transferred into a 1.5ml microcentrifuge tube. 
The tubing was washed with a small quantity of IX TBE to minimize the loss of DNA. 
The DNA was purified by phenoVchoroforom extractrion. The purified DNA was 
concentrated by absolute ethanol precipitation and then resuspended in 10^1 double 
distilled water for ligation reaction. 
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2.2.7 DNA ligation 
Dephosphorylated DNA vector was ligated with DNA fragment(s) by T4 DNA ligase. In 
10|il of liagation mixture, 3jil of the dephosphorylated DNA vector (-lOOng/^il) was 
ligated with 1.5^1 ofthe DNA fragment (-lOOng/^il) by T4 DNA ligase (200 units) in T4 
DNA NEBuffer fNew England BioLab). The ligation mixuture was incubated at room 
temperature for at least 3 hours. The ligation mixture (3|il) was added into 100^1 of 
competent cells for transformation. 
2.2.8 DNA dephsophorylation 
Restriction enzyme digested DNA vector was deophsophorylated by phosphatase to 
prevent self-ligation of the vector. The restriction enzyme digested DNA vector 
(2^g/40^1) was dephsophorylated by 0.5^1 of calf intensine phosphatase (0.5 unit) at 
37�C for 30 minutes. 
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2.2.9 In vitro site-directed mutagenesis 
2.2.9.1 The Sculptor ^ jn vitro mutagenesis 
The basic principle of the Sculptor™ in vitro mutagenesisis outlined in Figure 2.1. 
Mutant oligonucleotides covering the target sites were used as primer to synthesize the 
mutant strand. Briefly，a single-stranded DNA was prepared for the site-directed 
mutagenesis. Mutagenic oligonucleotide (l^il, 1.6pmoV|ul) was annealed with l|ig 
single-stranded plasmid containing the interested DNA fragment. The plasmid and 
oligonucleotide mixture was heated at 70�C for 3 minutes and then kept at 37�C in a 
water bath for 30 minutes. The mutated strand was synthesized and ligated in the 4.0 
units of Klenow polymerase and 2.5 units T4 DNA ligase. The polymerization reaction 
was incubated at 16°C for 16 hours. The polymerization reaction was stopped by the 
addition of heating at 70°C for 15 minutes. Single-stranded DNA template was removed 
by 2000 units of T5 exonuclease at 37�C for 30 minutes. Then the activity of T5 
exonuclease was heat inactivated at 70�C for 15 minutes. The non-mutant strand was 
nicked with 5 units of Nci I restriction enzyme at 37°C for 90 minutes. Then the nicked 
non-mutant strand was gapped by the addition of 160 units of exonuclease III at 37�C for 
30 minutes in order to remove the non-mutated strand. The gapping reaction was heat 
inactivated at 70°C for 15 minutes. Finally, the complementary-stranded of mutated 
strand was repolymerized in the presence of 3.5 units ofDNA polymerase I and 2.5 units 
ofT4 DNA ligase. The reaction was incubated at 37°C for 1 hour. The reaction mixture 
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was transformed into TG1 host cell. The success of mutagenesis was confirmed by 





/ " X Annea l ing 
( ) 70°C 3 minutes 
\ ^ � ^ ^ " " • " C i j ^ / ^ ^ ^ " ^ 3 7 � C 3 0 minutes 
s s D N A t ^ S l a t e V ) 4 .0 units KIenow DNA polymerase 
ssUNA template \ / 2.5 units T4 DNA ligase 
1 6 � C overnight (approximately l6h) 
or 
Extension & l igation 0.8 units T7 DNA polymerase 
w i th d C T P a S 1 2.5 units ligase 
勺 room temperature, 10 minutes 
37®C. 3 0 minutes 
^ ^ ^ 7 0 � C . 1 5 m i n u t e s 
R e m o v a l of f ( A | 2 0 0 0 units T5 exonuclease 
ssONA templa te Vv J ) 3 7 � C . 30 minutes 
\ ^ ^ — ' ^ 70"C. 15 minutes 
• i n g 5 units Nci I 
n o n - m u t a n t strand ^ 37"C. 90 minutes 
Or 
Gapp ing 160 units exonuclease III 
n o n - m u t a n t strand 丄 3 7 � C , 30 minutes 
勺 70°C. 15 minutes 
0 - 0 x 
3.5 units DNA poi I ^v. 
2.5 units ligase 
3 7 � C . 60 minutes Transformat io , 
Repo iymer i za t ion 
Figure 2.1 Schematic diagram of the Sculptor™ in vitro mutagenesis procedures. 
The single-stranded DNA with the interested gene annealed with the mutagenesis 
oligonucleotide. The mutated-strand DNA was synthesized by Klenow DNA polymerase 
and T4 DNA ligase at 16°C for ovemight. The non-mutated DNA template was removed 
by T5 exonuclease at 37°C for 30 minutes. The non-mutated-strand DNA was nicked 
with Nci I restriction enzyme at 37�C for 90 minutes. Then the nicked non-mutated 
strand was gapped by exonuclease III at 37�C for 30 minutes. Finally, the mutated 
double-stranded DNA was synthesized by DNA polymerase I and ligase and transformed 
to TGL (Adapted from the Sculptor in vitro mutagenesis technical manual (Amersham)) 
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2.2.9.2 The GeneEditor^ ^ in vitro site-directed mutagenesis 
Site-directed mutagenesis created by GeneEditor™ in vitro site-directed mutagenesis 
system was screened by co-mutation of the antibiotic resistance gene of vector as 
outlined in Figure 2.2. A single-stranded DNA template was prepared before the 
mutagenesis reaction. Double stranded plasmid (2^g) in 18 i^l was denatured with 2^1 of 
2M sodium hydroxide/2mM EDTA at room temperature for 5 minutes. The DNA was 
precipitated with 75^1 of absolute ethanol and 2\A of 2M ammonium acetate ^)H 4.6) at 
-70�C for 30 minutes. The DNA was centrifugated at 1300rpm in a micro-centriftige at 
4°C for 15 minutes. Then, the denatured DNA was washed with 200^1 of 70% ethanol 
and the DNA was air-dired. The denatured DNA pellet was resuspended in lOO i^l ofTE 
buffer (pH 8.0) and then analysed by agarose gel electrophoresis to test the efficiency of 
the denaturation. 
Denatured DNA template (200ng in lO^il) was annealed with phosphorylated mutagenic 
oligonucleotides (lp.1 of 1.25pmoV^l) and appropriately selected phosphorylated 
oligonucleotide (l^il of 0.25pmol/|il) which encodes mutations that alter the ampicillin 
resistance gene, creating a new additional resistance to the GeneEditor™ Antiboitic 
Selection Mix produced by the manufacture (Promega). To annealing reaction mixture 
10X annealing buffer (2jil) were added and made to 20p,l with double distilled water. 
The reaction was incubated at 75°C for 5 minutes, and then the annealing mixture was 
cool down slowly to 37�C in a beaker containing 200ml of water. The annealing 
temperature is depending on the melting temperature of the mutagenic oligonucleotides. 
47 
i n s e r t 
^3 
1 . A l k a l i n e d e n a t u r e d s D N A t e m p l a t e , 
a n n e a l m u t a g e n i c o l i g o n u c l e o t i d e 
“ a n d S e l e c t i o n O l i g o n u c l e o t i d e . 
- A > » o 
2 . S y n t h e s i z e m u t a n t s t r a n d 
w i t h T 4 D N A P o l y m e r a s e 
，' a n d T 4 D N A L i g a s e . 
r\ 
y 3 . T r a n s f o r m B M H 7 1 - 1 8 mulS c e l l s 
^ j j w i t h m u t a g e n e s i s r e a c t i o n . G r o w 
" ^ > ^ 夕乂 o v e r n i g h t w i t h t h e G e n e E d i t o r ™ 
^ ^ • • - - ; ^ ^ A n t i b i o l i c S e l e c t i o n M i x . 
i n s e r t m u t a n t 
V v l _ _ , ^ Am" V：;^_^ 
z n e w r e s i s t a n c e 4. i s o l a t e p l a s m i d D N A a n d t r a n s f o r m 
I J M 1 0 9 . S e l e c t m u t a n t s o n a m p i c i l l i n 
X ^ p l a t e s c o n t a i n i n g t h e G e n e E d i t o r ' " 
^ N A n t i b i o t i c S e l e c t i o n M i x . 
0 
Figure 2.2 Schematic diagram of the GeneEditor™ in vitro mutagenesis 
procedures. (Adapted from GeneEditor™ in vitro mutagenesis technical manual 
(Promega)) 
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The mutant strand was synthesized and ligated in the presence of T4 DNA polymerase 
(lU), T4 DNA ligase (lU), in the DNA synthesis buffer, and the final reaction volume 
was made to 30|il with double distilled water. The mutant strand was polymerized and 
ligated at 37�C for 90 minutes. Mutagensis mixture (1.5^1) was transformed into BMH 
71-18 mutS competent cells (100^1). The repair system of BMH 71-18 mutS cells was 
inhibited and as a result the selection against the desired mutation was avoided. The 
BMH 71-18 mutS cells was grown in 4ml LB with 100^1 of GeneEditor™ Antibiotic 
Selection Mix at 2>TC for 16 hours to 18 hours. Only cells that were transformed with 
the mutagenic plasmids survived in the GeneEditor^^ Antibiotic Selection Mix. The 
mutagenic plasmid was prepared by ovemight culture. In order to completely segregate 
the mutagenic plasmid with wild type plasmid, the mutageneic plasmid was second 
transformed into 100^1 of JM 109 competent cells. The transformed JM 109 was grown 
on a 20ml LB agar plate with 150^1 o f G e n e E d i t o r T M Antibiotic Selection Mix and 50^1 
of 50mgAnl amplicillin. Finally, mutations were confirmed by double-stranded DNA 
sequencing. 
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2.2.10 Double-stranded or single-stranded DNA sequencing by T7 
DNA polymerase sequencing system (Pharmacia) 
The double-stranded DNA template was denatured by sodium hydroxide. DNA template 
(2|<ig in 9^1) was denatured by the addition of ljil denaturing buffer (2M sodium 
hydroxide, 2mM EDTA) at room temperature for 5 minutes. The denatured DNA 
template was neutralized and precipitated by 2^il of 3M sodium acetate Q)H 5.2), 8 i^l of 
double-distilled water and 60^il of absolute ethanol at -70°C for 1 hour. The denatured 
DNA was collected by centrifugation at 13000 rpm with a table-top centrifuge for 15 
minutes. The DNA pellet was washed with 200^il of 70% ethanol and the pellet was air-
dired. The denatured DNA pellet was resuspended in lO^il of double-distilled water. 
Denatured DNA template (2^g) or single-stranded DNA template (ljug) in lO i^l were 
annealed with 2^1 of 2.5^iM to 5.0^M primer and 2^1 of annealing buffer ( lM Tris-HCl, 
pH 7.6，100mM MgCl� and 160mM DTT) at 65�C for 5 minutes. Cooled slowly at room 
temperature in 30 minutes. The annealed DNA template was labeled with 3^1 oflabeling 
mix-dATP (1.375^iM dCTP, 1.375^M dGTP, 1.375^iM dTTP and 333.5mM NaCl), 1^1 
of a-35S-dATP (lO^Ciy^^l) and 2|il of diluted T7 DNA polymerase in a final volume of 
20^il at room temperature for 5 minutes. During the incubation, 2.5|ul of ‘A，Mix-Short 
(840^iM dCTP, 840^iM dGTP, 840piM dTTP, 93.5^iM dATP, 14^iM ddATP, 40mM Tris-
HCl, pH 7.6 and 50mM NaCl), ‘C，Mix-Short (840^iM dATP, 840^iM dGTP, 840^iM 
dTTP, 93.5^iM dCTP, 14 i^M ddCTP, 40mM Tris-HCl, pH 7.6 and 50mM NaCl), ‘G’ 
Mix-Short (840^iM dATP, 840^iM dCTP, 840^iM dTTP, 93.5^tM dGTP, 14 i^M ddGTP, 
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f ) . 
40mM Tris-HCl, pH 7.6 and 50mM NaCl) or ‘T，Mix-Short (840^iM dATP, 840^iM 
dCTP, 840^iM dGTP, 93.5^iM dTTP, 14^iM ddTTP, 40mM Tris-HCl, pH 7.6 and 50mM 
NaCl) was added into four tubes then incubated at 37°C for 1 minute. The labeling 
reaction was terminated by removing 4.5^il of the labeling mixture to a pre-warmed 
termination mixes at 37�C for 5 minutes followed by 5^il of Stop solution (0.3% 
bromophenol blue, 0.3% xylene cyanol FF, lOmM EDTA, pH 7.5, 97.5% deionined 
formamide). The samples were stored at -20°C until use. For sequencing, the samples 
were denatured at 75°C to 80°C for 2 minutes and chilled on ice before loading on the 
sequencing gel. 
2.2.11 Denatured Polyacrylamide Gel Electrophoresis 
Sequencing polyacrylamide gel setup of 0.4mm thickness was assembled. The bottom of 
the setup was sealed with adhesive tapes. A 6 % denatured polyacrylamide gel was 
mixed according to Table 2.1. A gel plug was made by mixing 5ml of 6 % denatured 
polyacrylamide gel with 30^il of 20% ammonium persulfate (AP) and lO i^l ofN,N,N',N'-
tetramethylethylenediamine (TEMED). The gel was mixed gently and pipette into the 
sequencing setup slowly. Then, the gel plug was left to polymerize for 5 minutes. The 
rest ofthe 6 % denatured polyacrylamide gel was mixed with 230^1 of 20% AP and 43^1 
of TEMED. The denatured gel was mixed gently and pipetted into the sequencing setup 
slowly. The denatured gel was allowed to polymerize ovemight. 
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The polymerized denaturing polyacrylamide gel was attached to the electrophoresis 
apparatus. The top reservoir was filled with 0.5X TBE and the bottom reservoir with IX 
TBE. The gel was pre-run at a constant power of 80W. When the temperature of the 
running gel was reached approximately 50�C. DNA sequencing samples was prepared. 
The DNA sequencing samples were denatured at 80�C for 5 minutes and then chill on ice. 
Before loading the samples, the wells were washed with top buffer in order to remove 
urea in the wells. A denatured DNA sequencing sample (2^1) was loaded into each well. 
The required time was estimated by monitoring the migration of the marker dyes 
(bromophenol blue and xylene cyanol FF) in the DNA sequencing sample buffer 
according to Table 2.2. 
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Table 2.1 Composition of denaturing polyacrylamide gel 
^ 8 ^ 
7M Urea 42.00ml 42.00ml 
10XTBE 6.00ml 6.00ml 
40% Polyacrylamide 9.00ml 12.00ml 
double distilled water, 3.00ml 0.00ml 
Table 2.2 Migration rates of DNA sequencing marker dyes through 
denaturing polyacrylamide gels 
Percentage of gel Bromophenol blue Xylene cyanol FF 
^ 26 bps 106 bps 
8% 19 bps 76 bps 
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2.2.12 Nucleotide sequence of sequencing primers and 
mutagenic oilgonucleotides 
The mutation sequences o f E S l , ES2 and ES3 mutants were confirmed with e6 primer 
(5 'TGGACGTCGTCTAATGG3') while those of ES4 and ES5 e9 primer 
(5'AGTATGGTGTCCGATTC3'). The nucleotide sequences of the mutagenic 
oligonucleotides (ES1, ES2, ES3, ES4 and ES5) are shown in the Table 2.3. 
Table 2.3 DNA sequence of the mutagenic oligonucleotides 
Primer Mutagenic oligonucleotide DNA sequences 
name  
E ^ 5'-CGTGTTATTGCGATTGGC-3， 
E ^ 5'-GCTGAAGGCGATGCAGAC-3' 
E ^ 5'-CGATGCAGGCTTATAAGG-3， 
ES4 5'-GGAACCAAAAGCCTCGGAGGCATTG-3' 
E ^ 5'-GAACCAAAAAGCGCGGAGGCATTG-3， 
54 
2.3 Results 
2.3.1 Design exuperantia mutant constructs 
Potential phosphorylation residues of a protein are serine, threonine and tyrosine. In this 
regard, exu protein have 64, 24 and 13 of serine, threonine and tyrosine residues, 
respectively. Removal of all these serine, threonine and tyrosine residues on exu protein 
is nearly impossible. Therefore, the conserved amino acids residues of phosphorylation 
will be removed. 
Endogenous exu protein cannot be recognized by anti-phosphotyrosine antibody and 
therefore it is believed that there is a very low, if any, level of tyrosine phosphorylation 
on exu protein. However, non-specific and serine or threonine specific phosphatase 
reduce the phosphorylation isoforms of endogenous exuperantia protein. Therefore, the 
phosphorylation of exuperantia protein is marking on the serine and threonine residues. 
(Cheung, 1997). 
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2.3.1.1 Comparison of exu protein amino acids sequence with 
different Drosophila species 
The bacteriophage libraries of Drosophila virilis and Drosophila pseudoobscura 
genomic DNAs were screened by low stringency hybridization with a Drosophila 
melanogaster exu gene probe (Luk, et al., 1994). Several copies of the same Drosophila 
virilis exu and two different Drosophilapseudoobscrua exu {exuX and exu2) were found. 
The function of exuperantia protein is highly conserved among different species of 
Drosophila, Drosophila melanogaster, Drosophila pseudoobscura, and Drosophila 
virilis (Luk et al., 1994). Indeed, the exuperantia proteins of Drosophila pseudoobscura 
and Drosophila virilis totally rescue the exu phenotype in Drosophila melanogaster 
ovary. 
The amino acids homologies of all predicted exu protein sequences are 55-70% identical. 
Two highly conserved domains (amino acids 27-100 and amino acids 273-295) show 
greater than 90% of identity in the amino acids residues for all but the Drosophila 
pseudoobscrua exu2 protein (80-85% identifical) as showed in Figure 2.3. 
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Figure 2.3 The amino acid sequence alignment of the highly conserved domains 
and the PEST domain of different Drosophila species exuperantia protein. All of the 
PKA, PKC and PKG phosphorylation residues serine and therionine are coloured in red. 
The highly conserved domain of exuperantia protein from amino acids 27 to 100 have 
seven PKA, PKC and PKG specific phosphorylation residues，they are threonine 42, 
threonine 43, threonine 58，threonine 60, serine 87, serine 96 and threonine 99. The 
predicted PEST domain from amino acids 275 to 290 have four PKA, PKC and PKG 
specific phosphorylation residues, they are serine 275, serine 277, serine 285 and serine 
286. The other highly conserved domain of exuperantia protein from amino acids 320 to 
355 have three PKA, PKC and PKG specific phosphorylation residues, they are serine 
323, threonine 334 and threonine 335. 
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100 
D, melanogester yRMLKSMQTY 
D. virilis p  
D, pseudoobscura exul  
D. pseudoobscura exu2  
2 7 3 2 9 5 
D. melanogester QLSNSDGKPEPK-• • SSEALENMFNA 
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PEST domain 
3 2 0 
ZX melanogester RQNSFRPVFLNYFKTTLYHRVRAVKFRIVLAE D. virilis  
D. pseudoobscura exul ^  
D. pseudoobscura exu2 R NY Y--G  
3 5 5 
D. melanogester ^GFO 
D. virilis  
D. pseudoobscura exul T 
D. pseudoobscura exu2 H--T 
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As aforementioned, phosphorylation of exuperantia protein is predominatly 
phosphorylated by PKA, PKC and PKG. Therefore, the phosphorylation of exu protein 
most likely on the PKA, PKC and PKG phosphorylation sites. The consensus 
phosphorylation amino acid sequences ofPKA, PKC and PKG are shown in Table 2.3. 
Five exuperantia gene mutant constructs were designed, ES1, ES2, ES3, ES4 and ES5. 
The DNA sequences and the amino acid sequences of the constructs were shown in 
Figure 2.4. For the ES1 construct, the amino acid sequence Arg-Val-Ile-Ser is the 
consensus phosphorylation site of PKA, PKC and PKG. For the ES2 construct, the 
amino acids sequence Arg-Met-Leu-Lys-Ser is the consensus phosphorylation site of 
PKG. For the ES3 construct, the amino acids sequence Lys-Ser-Met-Gln-Thr-Tyr-Lys is 
the consensus phosphorylation site of PKC and PKG. For the ES4 construct, the serine 
285 is located at the predicted PEST domain of exu protein. For ES5 construct, the 
amino acids sequence Lys-Ser-Ser is the consensus phosphorylation site of PKA, PKC 
and PKG. The phosphorylation pattem of the mutant constructs will be studied by in vivo 
and in vitro phosphorylation systems. 
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Table 2.4 The consensus amino acid sequences and phosphorylation frequencies 
ofphosphorylation sites PKA, PKC and PKG 
Protein kinase Motif Frequency 




Protein kinase C S*/T*XK7R 20/37 
K/RXXS*/T* 13/37 
K / R X X S * / T * X K ^ 7/37 
Ky^RXSYT 10/37 
K7RXS*/T*XK/R 6/37 





The amino acid sequence shows in the one-litter amino acids code. The bold litter and 
the star (*) indicate the specific determine residues and specific phosphorylation residues 
ofthe phosphorylation sites respectively. (Adapted from Pearson and Kemp, 1991) 
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Figure 2.4 DNA and amino acid sequences of the exu mutants constructs: ES1, 
ES2, ES3, ES4 and ES5. The serine or threonine residues (red) on exu protein will be 
removed. The potential phsophorylation residues (serine and threonine) were changed to | 
non-phosphorylate amino acid such as alanine by in vitro site-directed mutagenesis. For 
ES1, serine 87 was changed to alanine by changing TCG to GCG. For ES2, serine 96 
was changed to alanine by changing TCG to GCG. For ES3, threonine 99 was changed 
to alanine by changing ACT to GCT. For ES4, serine 285 was changed to alanine by | 
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exu construct DNA sequences Amino acid sequences 
87 
Wild type 5'GTTATTTCGATTGG3' Arg Val Ile Ser Ile Gly i i ES1 5'GTTATTGCGATTGG3' Arg Val Ile Ala Ile Gly 
96 
Wild type 5 ‘CTGAAGTCGATGCA3 Met Leu Lys Ser Met 
V i ES2 5 ‘ CTGAAGGCGATGCA3 Met Leu Lys Ala Met 
99 
Wild type 5 ,ATGCAGACTTATTAT3, Ser Met Gln Thr Tyr Lys 
ES3 5 ,ATGCAGlcTTATTAT3, Ser Met Gln A a Tyr 
285 Wild type 5,CCAAAAAGCTCGGAG3 Glu Pro Lys Ser Ser Glu 
ES4 5'CCAAAAMcTCGGAG3 Glu Pro Lys A aSer Glu 
286 Wild type 5'CCAAAAAGCTCGGAG3 Glu Pro Lys Ser Ser Glu 
>^ \f ES5 5'CCAAAAAGCGCGGAG3 Glu Pro Lys SerA a Glu 
eo 
2.3.2The exu genomic mutant constructs 
For the ES1, ES2 and ES3 mutagenesis reactions, the 1.4kb Bgl II fragment of exu 
genomic DNA (p552) was subcloned into the BamR I digested M13mp8 replicative form 
(double-stranded DNA) (pl001) (Figure 2.5). For the ES4 and ES5 mutagenesis 
reactions, the 542bp Bgl lVPst I fragment of exu genomic DNA (p552) was subcloned 
into the BamYL VPst I restriction sites of the M13K11 replicative form (pl003) (Figure 
2.6). 
The single-stranded DNA of pl001 and pl003 were prepared. The single-strands were 
served as templates of the Sculptor in vitro site-directed mutagenesis reactions. The 
mutations were confirmed by double-stranded or single-stranded dideoxy sequencing. 
The DNA sequences ofESl , ES2, ES3, ES4 and ES5 are shown in Figures 2.7，2.8，2.9， 
2.10 and 2.11, respectively. 
2.3.3 The exu cDNA mutant constructs 
The pGEM-I vector containing the exu cDNA sequence (p556) (Figure 3.3) was used to 
serve as a template for the GeneEditor™ in vitro site-directed mutagenesis reaction. The 
mutations were confirmed by double-stranded dideoxy sequencing. The DNA sequences 
ofES2, ES3, and ES4 are shown in Figures 2.12, 2.13 and 2.14, respectively 
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Figure 2.5 Schematic diagram of the construction of pl001 plasimd. The pGEM-I 
vector containing the exu genomic DNA (p552) was digested with Bgl II restriction 
enzyme and the M13mp8 replicative form DNA (RF) was digested with BamH I 
restriction enzyme. The Bgl II exu fragment and the BamH I M13mp8 RF vector were 
purified by the electo=elution. The Bgl II fragment of the p552 was ligated with the 
BamHldigQStQd M13mp8 RF. The pl001 plasmid served as a template for the Sculptor 
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Figure 2.6 Schematic diagram of the construction of pl003 plasimd. The pGEM-I 
i 
vector containing the exu genomic DNA (p552) was digested with Bgl II and Pst I | 
1 
restriction enzymes and the M13mp8 replicative form DNA (RF) was digested with | 
i;l 
BamH I and Pst I restriction enzymes. The Bgl lVPst I exu fragment and the BamH I !Pst | 
I M13K11 RF vector were purified by the electo-elution. The Bgl II fragment of the ^ 
1. 
1-
p552 was ligated with the BamH I digested M13K11 RF. The pl001 plasmid served as a ；• j 
i- 1 [;！ 
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Figure 2.7 DNA sequences of wild type exu genomic DNA and genomic DNA 
mutant construct ES1. The DNA sequences of exu wild type and ES1 mutant construct 
were shown in panel A and panel B，respectively. The nucleotide T (denoted by red letter 
and red arrow) was mutated to G (denoted by green letter and green arrow) by in vitro 
site-directed mutagenesis. The wild type TCG serine codon (S87) (indicated by the red 
line) was changed to GCG alanine codon (A87) (green line). The S89 serine is a highly 
conserved serine residue of exu protein among different species of Drosophila with PKA, 
PKC and PKG concensus phosphorylation sequences. 
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Figure 2.8 DNA sequences of wild type exu genomic DNA and genomic DNA 
mutant construct ES2. The DNA sequences of exu wild type and ES2 mutant construct 
were shown in panel A and panel B, respectively. The nucleotide T (denoted by red letter 
and red arrow) was mutated to G (denoted by green letter and green arrow) by in vitro 
site-directed mutagenesis. The wild type TCG serine codon (S96) (indicated by the red 
line) was changed to GCG alanine codon (A96) (green line). The S96 serine is a highly 
conserved serine residue of exu protein among different species of Drosophila with PKA, 
PKC and PKG concensus phosphorylation sequences. 
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Figure 2.9 DNA sequences of wild type exu genomic DNA and genomic DNA 
mutant construct ES3. The DNA sequences of exu wild type and ES3 mutant construct 
were shown in panel A and panel B, respectively. The nucleotide A (denoted by the red 
letter and red arrow) was mutated to G (denoted by green letter and green arrow) by in 
vitro site-directed mutagenesis. The wild type ACT threonine codon (T99) (indicated the 
by red line) was changed to GCT alanine codon (A99) (green line). The T99 threonine is 
a highly conserved threonine residue of exu protein among different species of 
Drosophila with PKA, PKC and PKG concensus phosphorylation sequences. 
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Figure 2.10 DNA sequence of wild type exu genomic DNA and genomic DNA 
mutant construct ES4. The DNA sequences of exu wild type and ES4 mutant construct 
were shown in panel A and panel B, respectively. The nucleotides AG (denoted by red 
letter and red arrow) were mutated to GC (denoted by green letter and green arrow) by in 
vitro site-directed mutagenesis. The wild type AGC serine codon (S285) (indicated by 
the red line) was changed to GCC alanine codon (A285) (green line). The S285 is 
located on the PEST domain of exu protein and the PEST domain controls protein 
stability. Therefore, the ES4 mutant construct was used to investigate the relationship 
between exu protein phosphorylation and protein stability. 
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Figure 2.11 DNA sequences of wild type exu genomic DNA and genomic DNA 
mutant construct ES5. The DNA sequences of exu wild type and ES5 mutant construct 
were shown in panel A and panel B，respectively. The nucleotide T (denoted by red letter 
and red arrow) was mutated to G (denoted by green letter and green arrow) by in vitro 
site-directed mutagenesis. The wild type TCG serine codon (S286) (indicated by the red 
line) was changed to GCG alanine codon (A286) (green line). The S286 serine is a 
highly conserved serine residue of exu protein among different species of Drosophila 
with PKA，PKC and PKG concensus phosphorylation sequences. 
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Figure 2.12 DNA sequences of wild type exu cDNA and the cDNA mutant 
construct ES2. The DNA sequences of exu wild type and ES2 mutant construct were 
shown in panel A and panel B, respectively. The nucleotide T (denoted by red letter and 
red arrow) was mutated to G (denoted by green letter and green arrow) by in vitro site-
directed mutagenesis. The wild type TCG serine codon (S96) (indicated by the red line) 
was changed to GCG alanine codon (A96) (green line). The S96 serine is a highly 
conserved serine residue of exu protein among different species of Drosophila with PKA, 
PKC and PKG concensus phosphorylation sequences. 
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Figure 2.13 DNA sequences of wild type exu cDNA and the cDNA mutant 
construct ES3. The DNA sequences of exu wild type and ES3 mutant construct were 
shown in panel A and panel B, respectively. The nucleotide A (denoted by red letter and 
red arrow) was mutated to G (denoted by green letter and green arrow) by in vitro site-
directed mutagenesis. The wild type AGC threonine codon (T99) (indicated by the red 
line) was changed to GGC alanine codon (A99) (green line). The T99 threonine is a 
highly conserved threonine residue of exu protein among different species of Drosophila 
with PKA, PKC and PKG concensus phosphorylation sequences. 74 
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Figure 2.14 DNA sequences of wild type exu cDNA and the cDNA mutant 
construct ES4. The DNA sequences of exu wild type and ES4 mutant construct were 
shown in panel A and panel B, respectively. The nucleotides AG (denoted by red letter 
and red arrow) were mutated to GC (denoted by green letter and green arrow) by in vitro 
site-directed mutagenesis. The wild type AGC serine codon (S285) (indicated by the red 
line) was changed to GCC alanine codon (A285) (green line). The S285 is located on the 
PEST domain of exu protein and PEST domain controls protein stability. Therefore, the 
ES4 mutant construct was used to investigate the relationship between exu protein 
phosphorylation and protein stability. 
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2.4 Discussion 
During the oogenesis, exu protein plays a key role that controls the bcd mRNA 
localization and anteroposterior axis formation of the Drosophila embryo. Our research 
group shows that localization of exu protein directly or indirectly depends on PKA. 
Moreover, exu protein is a phosphoprotein. It is hypothesized that the localization of exu 
protein is directly or indirectly related to phosphorylation. 
Potential phosphorylation residues of exu protein were removed by site-directed 
mutagenesis. The exu protein has 64 and 24 serine and threionine residues, respectively. 
The potential phosphorylation sites of exu protein will be removed systematically. The 
* \ 
priority of mutations is depending on the homology and conservation of the exu protein 
amino acids residues. The amino acids residues that are located in the highly conserved 
region with kinases (PKA, PKC and PKG) consensus phosphorylation sites have higher 
mutation priority. 
Based on the above reasons, five exu mutant constructs (ES1, ES2, ES3, ES4 and ES5) 
were designed. The mutations are located in highly conserved regions except the ES4 
and ES5. The amino acid residues chosen are specific phosphorylation residues of the 
kinases except the ES4 mutants. The PEST domain of a protein controls its protein 
stability. The ES4 and ES5 mutant is located at the predicted PEST domain of exu 
protein. Therefore, the ES4 and ES5 mutants examined the relationship between exu 
protein phosphorylation and exu protein stability. 
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The exu genomic mutant constructs were mutated by the Sculptor in vitro mutagenesis 
system (Amersham). The main reason for using Sculptor in vitro mutagenesis system is 
due to the high fidelity of its DNA polymerase. The DNA polymerase of the Sculptor in 
vitro mutagenesis system is T7 DNA polymerase and it contains the 3, to 5，exonuclease 
activity and the DNA proofreading activity. Moreover, the Sculptor in vitro mutagenesis 
system is a wildly used site-directed mutagenesis system. 
The high molecular weight (7229 bps) M13mp8 vector in the Sculptor in vitro 
mutagenesis system is not a good vector for subcloning a high molecular insert. 
Therefore, only a small exu fragment was subcloned into M13 vector for mutagenesis 
reaction. After the mutagenesis reaction, the exu fragment with the desired mutations 
will be subcloned to the Drososphila transforming vector by directional cloning. But exu 
sequence doesn't have any convenience restriction sites for the simple subcloning. 
Therefore, three exu fragments were ligated with a Drosophila transforming vector at the 
same time. The successful rate of the ligation was very low. Only the ES1 and ES2 
mutated exu genomic fragments were successfully subcloned into the Drosophila 
transforming vector. Therefore, I used the other new site-directed mutagenesis system to 
generate the exu cDNA constructs. 
Though PCR based site-directed mutagenesis is a commonly used method, it is not 
suitable for my experiment. Firstly, exu do not have any convenient restriction sites for 
叙 
subcloning and therefore a large exu fragment (about 3kb) has to be used as a template 
for the PCR based site-directed mutagenesis reaction. Secondly, the fieldity of the DNA 
77 
polymerase used in the PCR reaction is questionable. In this regard, the exu cDNA 
constructs were generated by the GeneEditor™ in vitro site-directed mutagenesis system. 
The use of the GeneEditor mutagenesis system has some advantages when compare with 
the PCR-based method and the Sculptor mutagenesis system in mutation of genomic 
constructs. The DNA polymerase of GeneEditor™ mutagenesis system is a high fieldity 
DNA polymerase一T4 DNA polymerase. Moreover, the pGEM-I vector containing exu 
DNA ¢)552 or p556) which are suitable for the GeneEditor™ mutagenesis system, so that 
complicated subcloning procedures can be avoided. 
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CHAPTER 3 Epitope tagging of exuperantia protein with human 
c-myc epitope 
3.1 Introduction 
The phosphorylation and localization patterns of exu proteins are stage-specific. It is 
hypothesized that exu protein regulates the bcd mRNA localization that is modulated via 
protein phosphorylation. Phosphorylation of exu protein can be examined by an in vitro 
assay in which in vitro translated exu protein is subjected to phosphorylation by either 
exogenous kinase or endogenous kinase in oocyte lysate. For studying the physiological 
role of exu protein phosphorylation, the exu mutant constructs were introduced into 
genome of Drosophila, and phosphorylation pattem of transgenic exu protein in the 
transgenic flies investigated. The main problem of this study is to distinguish the 
exogenous exu protein from the endogenous exu protein. Therefore, the exogenous exu 
protein will be labeled with an epitope and the protein can be easily distinguished from 
the endogenous exu protein by the anti-epitope antibody. 
Epitope tagging is a simple method to distinguish the endogenous protein from 
exogenous protein. It is a recombinant DNA technique for making a gene product 
immunoreactive to an already existing antibody (Munro and Phelham, 1984; reviewed by 
Jarvik and Telmer, 1998). This technique involves inserting a polynucleotides fragment 
of an epitope to an interested gene by PCR, DNA cloning or in vitro site-directed 
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mutagenesis. The basic principle of the epitope tagging is shown in Figure 3.1. 
Normally, the epitope tag can be placed at the N or C terminus of the target protein. It is 
because must proteins will tolerate additions more readily at the N or C terminus than at 
other sites. An epitope tagged protein is a fusion protein, however only few amino acids 
(typically 6 to 30) are added to the terminus upon addition of epitope tagging. New 
biological activity to the protein shall be minimized. Since, the epitope labeled target 
protein can be recognized by the anti-epitope antibodies which are commercially 
available, allowing us to investigate and study protein functions. 
Many validated eptiope-antibody combinations are commercially available for use in 
epitope tagging and they are shown in Table 3.1. No ideal epitope tag is suitable for all 
applications. For some eptiopes, only one antibody is available, for others there are 
multiple choices. Localization of exu protein in Drosophila oocyte has been investigated 
with an exu protein tagged with Acquroea victoria green fluorescent protein (GFP) at the 
C terminus or N terminus (Wang and Hazelrigg，1994). The function, localization and 
expression of exu-GFP fusion proteins during Drosophila oogenesis are similar to native 
exu protein. It has been shown that the C terminus and N terminus of exu protein can 
tolerante to the addition of an epitope. Therefore, the exu protein will be tagged with an 
epitope at the C terminus. 
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protein DNA sequence epitope tag sequence 
/ ^ 
I I Step 1 
1 Step 2 
^ ' ' 0 ^ 
I ^ I ^ RNA ) Step3 
\^^^ • tagged protein 乂 
^ ^ 勢 _ ^ 
Figure 3.1 Schematic diagram showing the principle of epitope tagging on a 
target protein In the first step, an epitope tag DNA sequence was inserted into the 5, or 
3, end of the target DNA sequence. In the second step, the DNA construct was 
transformed into the corresponding host e.g. E. coli or yeast. Finally, the tagged proteins 
were expressed in the host and recognized by commercially available anti-tag antibody. 
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Table 3.1 Commercially available epitope/antibody combinations  
Epitope Size Sequence Antibody Immunogen  
AU1 ~ ~ 6 ~ ~ DTYRYI AU1 BPV-1 
AU5 6 TDFYLK AU5 BPV-1 
Btag 6 QYPALT D11,F10 VP7 ofbluetongue virusues 
c-myc 10 EQKLISEEDL 9E10 Synthetic peptide: residues 408-439 
ofhuman c-myc gene product 
FLAG 8 DYKDDDDK M1，M2, M5 Synthetic peptide containing 
enterokinase cleavage site 
Glu-Glu 6 EYMPME or EFMPME GLU-GLU Synthetic peptide EEEEYMPME of 
polyoma virus medium T antigen 
HA 9 YPYDVPDYA 12CA5, Humaninfluenzavims 
3F10，HA. 11 hemagglutinin, HA 1 fragment, aa77-
aallO 
His6 6 HHHHHH 6-His, 6xHis, Recombinant His-tagged fusion 
HIS 11 protein 
HSV 11 QPELAPEDPED HSV.TAG® Synthetic peptide from HSV 
glycoprotein D 
HTTPHH 6 HTTPHH PHHTT Synthetic peptide 
PHHTTPHHTTPHHTT 
IRS 5 RYIRS IRS1 Synthetic peptide 
KT3 6 PPEPET KT3 SV40 large T antigen 
Protein C 12 EDQVDPRLIDGK HPC4 HumanproteinC 
S.Tag® 15 KETAAAKFERQHMDS S-protein A polypeptide ofPancreatic 
ribonuclease A 
T7 11 MASMTGGQQMG T7.Tag® LeaderpeptideofphageT7major 
capsid protein 
V5 14 GKPIPNPLLGLDST V5 PA^ ofparamoxyvirus SV5 
VSV-G 6 MNRLGK P5D4 Syntheticpeptide: C-terminal 15 
residues of vesicular stomaitis vims 
- glycoprotein  
(Adapted from Jarvik and Tehner,1998) 
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In this study, exuperantia protein will be tagged with a c-myc epitope at a c-terminus. It 
is because the c-myc epitope is commonly used and the anti-c-myc antibody can be used 
in Westem blot analysis and immunoprecipitation. The 3, end of the genomic and 
5 
I complementary DNA of exu were tagged with a polynucleotides which encoded for a ！ I 
i human c-myc epitope. The cDNA was used to produce the c-myc epitope tagged exu 
protein and the genomic DNA was introduced into the germline of Drosophila by P 
• I 
• 1 1 
i element-mediated transformation. The c-myc tagged exu protein will be recognized by 
monoclonal mouse anti-c-myc antibody 9E10 clone which is commercially available. 
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3.2 Materials and Methods 
3.2.1 Preparation of the c-myc epitope DNA fragment 
The c-myc epitope DNA fragment was produced by annealing the sense strand and anti-
sense strand of c-myc epitope. The sense and anti-sense strand of c-myc epitope is 
manufactured by Life-Technologies. Nucleotide sequences of c-myc sense and anti-
sense strands are shown in Figure 3.2. In lO i^l of annealing mixture, lOOpmol of the 
sense stand and anti-sense strand in the annealing buffer (O.lM Tris-HCl, pH7.6, lOmM 
MgCl2 and 16mM DTT) were heated up to 75�C for 5 minutes. Then，the annealing 
mixture was cool down slowly in a 500ml beaker containing 300ml distilled water at 
37�C to room temperature. The annealed DNA fragment was precipitated by sodium 
acetate/absolute ethanol precipitation. The precipitated DNA fragment was resuspended 
lO i^l of double-distilled water. 
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(A) 
c-myc epitope sense oligonucleotide 
5 ‘ GATCCGGAACAAAAATTAATTTCAGAAGAAGATTTATAAGCATGCCC3 , 
(B) 
c-myc epitope anti-sense oligonucleotide 
5 ‘ GGGCATGCTTATAAATCTTCTTCTGAAATTAATTTTTGTTCCG3 ‘ 
(C) 
c-myc epitope DNA fragment 
5 , GATCCGGAACAAAAATTAATTTCAGAAGAAGATTTATAAGCATGCCC3 ‘ 
3 ‘ GCCTTGTTTTTAATTAAAGTCTTCTTCTAAATATTCGTACGGG5 ‘ 
Mgure 3.2 DNA sequences of the c-myc epitope sense strand and anti-sense 
strand. Nucleotide sequence of sense (A) and anti-sense (B) human c-myc epitope. The 
c-myc epitope DNA fragment (C) has one sticky end {BamU I) and one blunt end for the 
directional cloning. The c-myc epitope DNA fragment was directionally cloned into the 
BamR VSma I digested p552 vector. 
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3.2.2 End-filling of 5，overhang DNA fragment by Klenow fragment 
The 5, overhang DNA fragment (40^il) was end-filled by Klenow fragment (lunit in 
0.5^il) in the presence of 2^il of 2mM dNTPs in a final volume of 42.5^1 at room 
temperature for 1 hour. The end-filling reaction was stopped by heating at 65�C for 15 
minutes. The end-filled DNA fragment was purified by phenol^hloroform extraction. 
The DNA was precipitated by absolute ethanol precipitation. Finally, the DNA fragment 
was resusupended in lO i^l of double-distilled water and 3^il of the end-filled DNA 
fragment was used in the ligation reaction. 
3.2.3 In vitro translation of protein by TNT® Quick coupled 
transcription and translation system 
For in vitro translation of exu protein, the interested cDNA template (2.5^g) were mixed 
with 60^ x1 of TNT® Quick Master Mix, 1.5^1 of 2mM methionine and make up the 
reaction volume to 75|il with nuclease-free water. For the labeling in vitro translated 
protein，L-[^^]methionine (30^iCi in 1.5^1) instead of 2mM methionine was used. The 
transcription and translation reaction mixture was incubated at 30�C for 1.5 hours. The 
translation reaction stopped by adding 200|il ofRIPA (150mM NaCl, 50mM Tns-HCl, 
pH 8.0，lmM EDTA, 1% NP-40, 0.5% DOC, 0.1% SDS，l.O^g/ml pepstatin, l.O^ig/ml 
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leupeptin, 1.0|igAnl aprotinin and 0.28mM PMSF) (Harlow and Lane, 1990) and 1^1 of 
0.5M EDTA. 
3.2.4 lmmunoprecipitation of recombinant exu protein 
The in vitro translated exu proteins were immunoprecipitated by 10|il of a rabbit 
polyclonal anti-exu antibody or by a mouse monoclonal anti-c-myc antibody (final 
concentration l-5^ig/ml) (Snyders, 1998). The reaction mixtures were incubated at 4°C 
with gentle shaking for 2 hours. Then 20^il protein G plus A agarose (Calbiochem) in 
MPA were added before further incubation at 4°C with gentle mixing for another 1.5 
hours. After incubation, the antibody complexes were collected by centrifugation at 
4500xg at 4�C for 5 minutes. The antibody complex pellets were washed with 0.5ml ice-
cold RIPA and then with 0.5ml ice-cold RIPA with phosphatase inhibitors (20mM p-
glycerophosphate, 20mM p-nitrophenylphosphate and lOmM sodium fluoride). Finally, 
the complexes were resuspended in 20)il of 2X SDS sample buffer (SB) (62.5mM Tris-
HC1, pH 6.8’ 2% SDS, 5% P-mercaptoethanol, 10% glycerol, 0.005% bromophenol blue) 
supplemented with lOmM EDTA and then boil the samples for 5 minutes. The boiled 
protein samples were stored at -20�C. And the samples were re-boiled for 5 minutes 
before loading to the SDS-PAGE. 
87 
3.2.5 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
3.2.5.1 SDS-PAGE preparation 
A 10% polyacrylamide gel mixture was prepared according to Table 3.2. To prevent 
leakage of gel solution from assemble, gel plug was made by mixing 6ml of 10% gel with 
33^1 of 20% ammonium persulphate (AP) and 13 ^1 of N,N,N,N,-tetramephylephylene 
diamine (TEMED). The gel plug mixtue was transferred into the gel setup with a Gilson 
P5000 pipetman slowly to avoid air bubbles formation and left to polymerize for 5 
minutes. To form the separating gel, the rest of 10% gel mix was mixed with 67\A of 
20% AP and 37 ^1 of TEMED, the mixture was transferred into the gel setup with a 
P5000 pipetman slowly. Since oxygen in the atmosphere can inhibit the polymerization 
reaction of polyacrylamide gel, a thin layer of water was added on the top of gel to 
prevent direct contact of gel with air. The separating gel was allowed to polymerize 
ovemight. 
A stacking gel solution was prepared according to Table 3.3. The stacking gel solution 
was then added with 70^il of AP and 30^il of TEMED. After the placement of proper 
comb the stacking gel was left to polymerize for 30 minutes. 
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Table 3.2 Composition of separating polyacrylamide gel 
1% 8% m 12.5% 15% i m 
Tris-HCl,L5M(pH8.8) 10.0ml 10.0ml 10.0ml 10.0ml 10.0ml 10.0ml 
Acrylamide, 40 % 5.0ml 8.0ml 10.0ml 12.5ml 15.0ml 20.0ml 
SDS, 20 o/o 0.2ml 0.20ml 0.2ml 0.2ml 0.2ml 0.2ml 
Water, double-distilled 24.8ml 21.8ml 19.8ml 17.3ml 14.8ml 9.8ml 
Table 3.3 Composition of stacking polyacrylamide gel 
^ 
Tris-HCl, 0.5M (pB 6.8) 5.0ml 
Acrylamide, 40% 2.5ml 
SDS, 20 % 0.1ml 
Water, (double-distilled) 12.4ml 
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3.2.5.2 SDS-PAGE electrophoresis 
Protein samples were boiled for 5 minutes before loading into the well. The boiled 
samples were centrifuge in a table-top micro-centrifuge at 13000rpm for 15 minutes in a 
micro-centrifuge tubes. The comb was removed slowly in order to prevent the distortion 
of the well. All the wells were washed by IX electrode buffer (25mM Tris-HCl, 250mM 
glycine and 0.1% SDS) in order to remove the non-polymerized gel. Protein samples 
were loaded into the wells by a Gilson P20 piptemen slowly. Equal samples volume of 
IX SDS sample buffer were loaded into the empty wells. The SDS-PAGE was running 
in constant current at 50mA for about 5-6 hours. 
3.2.6 Western blot analysis 
3.2.6.1 Transfer the protein to a nitrocellulose membrane by 
semi-dried blotting 
A nitrocellulose paper of the same size as the gel was pre-wetted by water. The gel and 
the nitrocellulose membrane were soaked in transfer buffer (4.8mM Tris-HCl, 4.0mM 
glycine, 2% SDS, 20% methanol) for 45 minutes. The gel and the nitrocellulose 
membrane were sandwiched in two pieces ofWhatman 3MM paper which had been pre-
wetted with transfer buffer. The gel, nitrocellulose membrane, and 3MM paper sandwich 
was placed on a semi-dry blotter, and excess buffer on the sandwich was removed. The 
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protein on the gel was transferred to the nitrocellulose membrane under a constant 
voltage of 15V for lhour and 15 minutes. 
3.2.6.2 Western blot blocking and antibody recognition 
At the end of the transfer, the nitrocellulose membrane was washed with TTBS (lOmM 
Tris-HCl, pH 7.5, 0.9 % NaCl, 0.05 % Tween 20). The non-specific sites on the 
membrane was blocked with 4 % skimmed milk in TTBS for 1 hour at room temperature. 
After blocking, the skimmed milk was replaced by a primary rabbit anti-exu antibody of 
1:1000 in TTBS with 1% bovine serum albumin (BSA). The membrane was incubated at 
4°C ovemight. After primary antibody incubation, the membrane was washed for three 
times at room temperature for 15 minutes with TTBS. Then the membrane was 
incubated at room temperature for 2 hours with secondary goat anti-rabbit antibody at a 
dilution of 1:5000 in TTBS with 1 % BSA. After the secondary antibody incubation, the 
membrane was washed for three times at room temperature for 15 minutes with TTBS. 
The membrane was developed with 0.033 % nitro blue tetrazolium 0s[BT) and 0.017 % 5-
bromo-4-chloro-3-indolyl phosphate disodium (BCIP) in AP buffer (lOOmM Tris-HCl, 
pH 9.5，100mM NaCl, 50mM MgCy. The color developing reaction was stopped by 
rinsing the membrane with a large amount of double distilled water for several times. 
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3.3 Results 
3.3.1 Construction of the plasmid containing exu cDNA tagging with a 
c-myc epitope 
The plasmid restriction map of pGEM-I vector containing the exu genomic DNA 0^552) 
and exu cDNA (p556) were shown in Figure 3.3. The exu cDNA was tagged with the c-
myc eptiope by molecular techniques. The cloning procedures of exu was outlined in 
Figure 3.4. The p552 plasmid was digested with the BamU I and Sma I restriction 
enzymes in order to generate the BamB. I and Sma I overhangs. The digested p552 was 
ligated with the c-myc eiptope DNA fragment. The insertion was confirmed by double-
stranded dideoxy sequencing (Figure 3.5) and restriction mapping (Figure 3.6). 
The 3'end ofthe exu genomic DNA was removed in the subcloning ofthe c-myc epitope 
fragment. The function of the exu 3'end is essential for its transcription or translation, 
therefore the exu 3'end should be inserted back to p552-myc plasmid. The p552 was 
digested with BamYi I restriction enzyme and the BamR I-digested fragment was purified. 
The sticky ends of the BamR I fragment end-filled by the Klenow fragment. The p552-
myc plasmid linearized by Sma I. The end-filled BamYL I fragment was ligated with the 
Sma I linearized p552-myc to form the p552-myc-Bam plasmid. Orientation of BamH I 
fragment was examined by restriction mapping (Figure 3.6) 
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(A) 
exu genomic seq. 
— I <-Sp6 promoter / ^tron ^^. ^ T7 promoter 
5 ^ “ U y ^ N o t I BamH I ^ ^ Xba I BamR I Sma I 
A T G ^ m C A A I I   
1.4kb 0.34kb 0.14kb 1.28kb 
p552 
(B) 
promoterseq. • coding seq. (1.7kb) BamU I 
\ I • / _• EcoKlXxbal Notl / Nsi\ EcoRI — 
T7 promoter L X j t 1 Sp6promoter 
l l l l i l l P A T G C A A I i 二 
1.5kb 0.48kb 0.08kb 
5' 3， p556 
Figure 3.3 Genetics maps of p552 and p556. The pGEM-I vector containing exu 
genomic fragment (Xba VXba I) and exu cDNA fragment (EcoR VEcoR I) are called 
p552 and p556, respectively. The exu coding sequence ofp556 is downstream ofthe T7 
pomoter and therefore T7 RNA polymerase was used in in vitro translation reaction. 
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Figure 3.4 Schematic diagram showing construction of the p556-myc construct. 
The exu genomic DNA and cDNA were tagged with the c-myc epitope. In the first step, 
p552 plasmid was digested with Sma I and BamR I restriction enzymes in order to 
generate a sticky end {BamU I) and a blunt end {Sma I) on p552. The second step, a 
DNA fragment containing c-myc epitope DNA sequence was inserted into the digested 
p552 vector by directional cloning. Then the p552-myc plasmid digested with Sma I 
restriction enzyme in order to generate two blunt ends. Meanwhile, p552 plasmid 
digested with BamB I restriction enzyme in order to generate the BamR I fragment. The 
sticky ends of BamYL VBamR I fragment were end-filled by the Klenow fragment. The 
blunt ended BamYi VBamR I fragment was ligated with the Sma I digested p552-myc 
plasmid and the orientation of the fragment was examined by the restriction fragment 
length polmorphorsim (RFLP). The endogenous stop codon of p552-myc-bam was 
removed by site-directed mutagenesis. The c-myc tagged Not VNsi I fragment of the 
p552-myc-bam-stop was exchanged with the wild type p556 fragment. Finally, exu 
cDNA was tagged with the c-myc epitope and the 3,UTR ofexu is remained. 
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Figure 3.5 DNA sequence of p552-myc plasmid. The anti-sense strand ofp552 was 
sequenced with Sp6 primer (5'CATACGATTTAGGTGACACTATAG3'). It shows that 
the c-myc epitope DNA fragment (blue-lettered) inserted at 3'end of p552. The 
endogenous stop codon of exu (red-lettered) is present in the p552-myc plasmid. 
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Figure 3.6 Agarose gel electrophoresis of p552 and p552-myc-Bam fragments. 
Panel A showed the genetic map of p552 and p552-myc-Bam. The major difference 
between these two plasmids are the Not VNsi I fragment of the p552-myc-Bam is greater 
than the fragment ofp552. It is because the exu genomic DNA labeled with the c-myc 
epitope. The orientation ofthe BamU I fragment inserted into the p552-myc plasmid was 
confirmed by digestion ofthe p552-myc-Bam and p552 plasmids with Nsi I and EcoR I 
restriction enzymes. Panel B showed the agarose gel electrophoresis ofthe p552 (lane 1 
and 3) and p552-myc-Bam plasmid (lanes 2 and 4) digested with Nsi/Not Land Nsi 
VEcoR I. In Lane M, it is the Sty I X DNA marker; In Lane 1, p552 plasmid digested 
with Nsi VNotI\ Lane 2，p552-myc-Bam plasmid digested with Nsi VNot I; In Lane 3， 
p552 plasmid digested with Nsi VEcoR I; In Lane 4，p552-myc-Bam digested with Nsi 
VEcoR I. The size of Not VNsi I fragment of p552-myc-Bam is greater than the fragment 
of p552. It is confirmed that the c-myc epitope DNA sequence was inserted into p552-
myc-Bam plasmid. The size ofNsi VEcoR I fragment of p552-myc-Bam is equal to Nsi 
VEcoR I fragment of p552. It is confirmed that the BamR I fragment of p552 was 
inserted in the correct orientation into the p552-myc vector. 
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The translation of the p552-myc-Bam will terminate at the endogenous stop codon ofexu 
which prevents the expression of c-myc epitope. Therefore, the p552-myc-Bam 
endogenous stop codon was removed by in vitro site-directed mutagenesis with 
GeneEditor™�The mutation was confirmed by DNA sequencing (Figure 3.7). 
The p552-myc-Bam-stop plasmid is not suitable for the in vitro translation reaction 
because it is exu genomic DNA constructs and the plasmid contains two introns. Thus, 
the Not VNsi I fragment of p552-myc-Bam-stop containing the c-myc epitope and the 
mutation on endogenous stop codon will exchange with the Not VNsi I fragment of p556. 
The myc-tagged Not VNsi I fragment of p552-myc-bam-stop was ligated with the Not 
VNsi I linearized p556 vector. The insertion of myc-tagged exu fragment into p556 
plasmid was confirmed by restriction fragment length polymorphism (Figure 3.8) and 
DNA sequencing (data not shown). 
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5‘AACTAAAATCCAGTTCTGGTGGATCCGGAACAAAAA 
3‘TTGGTTTTAGGTCAAGACCACCTAGGCCTTGTTTTT 
TTAATTTCAGAAGAAGATTTATAAGCATGCCCGTCCGT 3 ‘ 
AATTAAAGTCTTCTTCTAAATATTCGTACGGGCAGGCA 5 ‘ 
Figure 3.7 DNA sequence of p552-myc-Bam. (A) An autoradiography of p552-
myc-Bam sequencing gel and read-out. (B) The sense strand DNA sequence of p552-
myc-Bam 3'end indicated that the TAA stop codon (red lettered) was changed to CAA 
glutamine codon (green lettered) by Gene-Editor™ in vitro site-directed mutagenesis 
system. The c-myc eptiope DNA sequence (blue lettered) was inserted into the 3'end of 
exu. 
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Figure 3.8 Agarose gel electrophoresis of p556 and p556-myc. (A) Genetic maps 
ofp556 and p556-myc. The difference between p556 and p556-myc contains a 49bp c-
myc insertion. (B) The p556 and p556-myc plasmids were digested with Nsi/Not I. In 
Lane M, Sty I \ DNA markers; lane 1，p556 plasmid digested with Nsi VNotI\ lane 2, 
p556-myc plasmid digested with Nsi VNot I. The size of Not VNsi I fragment of p556-
myc is 49bp longer than the fragment of p556. It is confirmed that the c-myc epitope 
DNA sequence was inserted into the p556-myc plasmid. 
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3.3.2 In vitro translation of c-myc epitope tagged exu protein 
The coding region of exu cDNA in p556-myc plasmid is downstream of T7 promoter. 
The p556-myc served as a DNA template for the TNT® quick coupled transcription and 
translation system with T7 RNA polymerase. The c-myc labeled exu protein was 
produced and separated by SDS-PAGE. The protein was examined by Westem blot 
analysis (Figure 3.7). 
The protein blots were probed by either a rabbit polyclonal anti-exu antibody or a mouse 
monoclonal anti-myc antibody (Boehringer). Homozygous exu^ ^ ovaries extract served as 
a negative control while wild type ovary extract served as a positive control. The c-myc 
tagged exu protein (lane 2) and wild type exu protein (lane 1) can be detected by a rabbit 
polyclonal anti-exu antibody. But only the c-myc tagged exu protein (lane 2) can be 
detected by a mouse monoclonal anti-myc an t ibody� I t is suggested that the primary 
structure of c-myc tagged exu protein is specifically recognized by the anti-myc antibody. 
The insertion of c-myc epitope increased the size of the exu protein. Therefore, the 
mobility of the c-myc tagged exu protein (lane 2) is lower than the wild type exu protein 
(lane 1). 
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Figure 3.9 Western blot analysis of in vitro translated wild type exu protein and 
c-myc tagged exu protein. Expression of exu protein was detected by polyclonal rabbit 
anti-exu antibody(A) or by monoclonal mouse anti-myc antibody (B). Lane sc, the ovary 
extracts from homozygous ext^'\ lane w, the ovary extracts from w""; lane 1，the in vitro 
translation product of p556; lane 2, the in vitro translation product of p556-myc. 
Multiple isoforms of exu protein with different molecular weights can be detected in the 
wild type ovary extract. As a negative control, the ovary extract ofthe exvf' protein null 
mutant was run in parallel with that of the wild type. The c-myc tagged exu protein in 
lane 2 has a lower mobility than wild type exu protein in lane 1. Both the wild type and 
c-myc tagged exu protein can be detected by anti-exu antibody. But only the c-myc 
tagged exu protein can be detected by anti-myc antibody in panel B. 
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3.3.3 Immunoprecipitation of c-myc labeled exu protein by a 
polyclonal rabbit anti-exu antibody and monoclonal mouse anti-
myc antibody 
The in vitro translated c-myc labled exu protein and the wild type exu protein were 
immunopreciptiated with the anti-exu antibody or the anti-myc antibody. The 
immunoprecipitated protein complexes were separated by 10% SDS-PAGE and the exu 
proteins were detected by Westem blot analysis (Figures 3.10 and 3.11). 
) The Westem blot of anti-exu antibody immunoprecipitated proteins were probed with the 
anti-exu antibody (Figure 3.10). The exu protein (lane 2) and c-myc tagged exu protein 
(lane3) can be detected. It is suggested that the wild type exu protein and the c-myc 
tagged exu protein can be immunoprecipitated by the anti-exu antibody. 
The Westem blots of anti-myc antibody immunoprecipitated proteins were probed with 
the anti-exu antibody and the anti-myc antibody (Figure 3.11). Both of the wild type 
(lane 2) and c-myc tagged exu protein (lane 3) cannot be detected. It is suggested that the 
wild type and c-myc tagged exu protein cannot be immunoprecipitated by the anti-myc 
antibody or the immunopreciptiated protein was not sufficient to be detected. 
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Figure 3.10 Western blot analysis of anti-exu antibody immunoprecipitated wild 
type and c-myc tagged exu protein. The Westem blot was probed by an anti-exu 
antibody. Lane sc, the ovary extracts from homozygous exu"^; lane w, the ovary extracts 
from w"'"^; lane 1, the in vitro translation product of pGEM-l; lane 2, the in vitro 
translation product of p556; and lane 3，the in vitro translation product of p556-myc. 
Multiple isoforms of exu protein with different molecular weights can be detected in the 
wild type ovary extract. As a negative control, the ovary extract of the exu"�protein null 
mutant was run in parallel with that of the wild type. hi lane 2 and 3, the exu proteins 
were detected. It shows that the wild type and c-myc tagged exu protein can be 
immunoprecipitated by anti-exu antibody. 
105 
i • • , 
‘ Anti-exu Anti-mvc 
M sc w 1 2 M sc w 1 2 
M r r i 
I' . 
! 120.0 • 
I “ 
I 8 4 . 0 • 
. , _ 
62.0 • 
。*^一=^ «^、， 
5 1 . 0 • … ‘ 
I �一- , 




I • i I 
I . 
I 
Figure 3.11 Western blot of anti-myc antibody immunoprecipitated wild type and 
c-myc tagged exu protein. In the left panel, the Westem blot was probed by a 
polyclonal rabbit anti-exu antibody; in the right panel, the westem blot was probed by a 
monoclonal mouse anti-myc antibody. Lane sc, the ovary extracts from homozygous 
exi^ \^ lane w, the ovary extracts from w""; lane 1，the anti-myc antibody 
immunoprecipitated in vitro translation product of p556; and lane 2，the anti-myc 
antibody immunoprecipitated in vitro translation product of p556-myc. Multiple 
isoforms of exu protein with different molecular weights can be detected in the wild type 
ovary extract. As a negative control, the ovary extract of the extf^ protein null mutant 
was run in parallel with that of the wild type. The wild type and c-myc tagged exu 
protein can not be detected. 
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To examine whether enough amount of c-myc tagged exu protein was 
immunoprecipitated by anti-myc antibody, the in vitro translated c-myc tagged exu 
protein and the wild type exu protein were labeled with L-[^^S]-methionine. The labeled 
exu proteins were immunoprecipitated by anti-myc antibody. The protein complexes 
were separated by SDS-PAGE. The exu proteins were directly visualized by 
autoradiography (Figure 3.12). The c-myc tagged exu protein (lane3) was visualized on 
the X-ray film. While normal exu protein was not detected, the c-myc tagged exu protein 
was successfully immunoprecipitated with the anti-myc antibody. 
‘ 
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Figure 3.12 Western blot analysis of anti-myc antibody immunoprecipitated L-
[35S]-methionine labeled wild type and c-myc tagged exu protein. The wild type and 
c-myc tagged exu protein was immunoprecipitated by anti-myc antibody. Lane sc, the 
ovary extracts from homozygous exif^; lane w, the ovary extracts from w"!"^ ; lane 1，the 
anti-myc antibody immunoprecipitated in vitro translation product of p556; lane 2, the 
anti-myc antibody immunoprecipitated in vitro translation product of p556-myc. The L-
"35]methionine labeled c-myc tagged exu protein can be detected in lane 2. It shows that 
c-myc tagged exu protein can be immunoprecipitated by anti-myc antibody. 
108 
3.4 Discussion 
An epitope can be placed at the C terminus, N terminus, intemal sites or both of a protein 
(Jarvik and Telmer, 1998). Theoretically, putting an epitope at either termini is much 
better than at the intemal site of a protein. It is because protein tolerates the additions 
more readily at the termini than at intemal sites. For example, exu protein was tagged 
with a GFP protein (Wang and Hazelrigg, 1994). The GFP protein was fused with C 
terminus of exu protein. The localization and the function of exu-GFP constrcut are 
similar to the wild type exu protein. It is suggested that C terminus of exu protein 
tolerates the addition of an epitope. Therefore, a single c-myc epitope was added to the C 
terminus of exu protein. 
The reason of using c-myc epitope because this epitope and the ant-myc antibody are 
well established and characterized. The c-myc epitope labeled exu protein can be 
detected and immunoprecipitated by a mouse anti-myc antibody (9E10 clone) 
(Boehringer) and the rabbit polyclonal anti-exu antibody. Meanwhile, the unlabeled exu 
protein (wild type) is only detected and immunoprecipitated by the rabbit polyclonal anti-
exu antibody. The advantage of tagging exu protein with c-myc epitope is that 
exogenous exu protein (c-myc labeled) and endogenous exu protein can be distinguished 
by anti-myc antibody. 
In the future experiments to be described latter, transgeneic exu constructs were labeled 
with the c-myc epitope before transformed into the genome of Drosophila. The 
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expression and localization of transgenic protein can be distinguished from the 
endogenous exu protein in the exu transgenic flies. The advantages of this procedure are 
that the times and labors of the segregation crosses can be saved. 
For exu protein phosphorylation assay, the endogenous kinases system (ovary extract) 
can also be examined in addition to the exogenous kinases system (PKA, PKC and PKG). 
The recombinant c-myc labeled exu protein that added into ovary extract can be easily 
distinguished from endogenous exu protein by the anti-myc antibody. 
The immunoprecipitation of c-myc tagged exu proetein by a mouse monoclonal anti-myc 
antibody can not be detected on Westem blots (Figures 3.11 and 3.12). The exu-myc 
protein can be recognized by the anti-myc antibody on the Westem blot of in vitro 
translated protein. It is suggested that the translation of the c-myc eptiope is normal. 
Moreover, the L-[^^]methionine labeled exu-myc protein can be detected by auto-
radiography. It suggests that the c-myc labeled exu protein expressed normal and can be 
immunoprecipitated by a mouse monoclonal anti-myc antibody, however the efficiency 
of the immunoprecipitation is a problem. The immunogeneicity of the exu-myc is not 
very high because only one c-myc epitope was fused with the exu protein. Multiple c-
myc epitope inserted into the exu protein might increase the immunogenicity and 
efficiency of immunopreciptiation (Jarvik and Telmer, 1998). At the same time, it also 
increases the risk that the epitopes will interfere with the protein function. 
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CHAPTER 4 In vitro phosphorylation of exuperantia protein 
4.1 Introduction 
The Westem blot analysis indicates that endogenous exu protein is a phosphoprotein and 
the recombinant exu protein can be phosphorylated by exogenous kinases (PKA, PKC 
and PKG). The phosphorylation pattem of exuperanita protein is stage specific, and the 
exu protein and bicoid mRNA are co-localization in some developmental stages. It may 
suggest that the bcd mRNA localization and the exu protein phsophorylation are 
functionally related. However, the physiological function(s) and the role(s) of exu 
protein phsophorylation are still unknown. 
To identify potential phosphorylation sites, mutations were introduced into the exu cDNA 
constructs, ES2, ES3 and ES4 by GeneEditor^^ in vitro site-directed mutagenesis system. 
The mutated exu protein variants were produced by TNT® in vitro transcription-
translation coupling system. Phosphorylation of exu mutants were examined by in vitro 
phosphorylation assay with PKA, PKC and PKG. We reasoned that if the putative 
phosphotylation site of exu protein is removed, the exu mutated protein will not be 
phsophorylated. For example, phosphorylation of fushi tarazu protein have been studied 
with a similar approach (Dong et al., 1998). The T263D flishi tarazu mutant protein 
showing a different pattem and level of phosphorylation with that of wild type fushi 
tarazu protein, suggesting that the 263 tyrosine residue of fushi tarazu protein is the 
specific phosphorylation residue. 
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In my experiment, the exupernatia cDNA mutant constructs (ES2, ES3 and ES4) were 
used to produce various exu protein variants with an in vitro transcription-translation 
coupling system. It is a prokaryotic in vitro transcription system (T7 RNA polymerase) 
with an eukaryotic (rabbit or wheat germ) in vitro translation system. The major 
components of the TNT translation system are T7 or SP6 RNA polymerase, in 
combination with the translation system of rabbit reticulocyte or wheat germ. A plasmid 
containing the interested gene served as a DNA template for the RNA polymerization by 
T7 or SP6 RNA polymerase. The main reason of using TNT in vitro translation system 
instead of bacteria expression system is that the bacterial exu protein is not very soluble 
in the phosphorylation buffer. But the in vitro translated exu protein is present in the 
soluble form and it is more suitable for the phosphorylation assay. 
The exuperantia cDNA constructs were cloned into a pGEM-I vector (p556). The 
pGEM-I vector has two promoters, T7 promoter and SP6 promoter. The exu cDNA 
inserts are put downstream of the T7 promoter. Therefore, the T7 RNA polymerase was 
used to produce exu RNA. The exu protein constructs were produced by a translation 
system ofrabbit reticulocyte. After that, the in vitro translated exu proteins were purified 
by immunoprecipitation with a rabbit polyclonal anti-exu antibody and then the purified 
protein complexes were used to perform in vitro phosphorylation assay with PKA, PKC 
and PKG and labeled with [^^P]ATP. Finally, the phosphorylated protein complexes 
were separated by SDS-polyacrylamide gel electrophoresis. The pattem and level of 
protein phosphorylation were visualized by autoradiography. 
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4.2. Materials and methods 
4.2.1 Exogenous kinase phosphorylation reactions 
The immunoprecipitated exu protein complexes were washed twice with 50mM Tris-HCl, 
pH 8.0，150mM NaCl before being resuspended in the respectively kinase buffer. The 
immunoprecipitated exu protein complexes were resuspended in 24.5^1 of double-
distilled water. In each kinase reaction, twenty microcuries (^iCi) of [y-^^P]ATP (l|al) 
(Amersham, specific activity>5000 Ci/ml), plus PKA (0.5^il) (46 units) (Promega), PKC 
(0.5^d) (7.5 units) (Calbiochem) or PKG (0.5]Lil) (175.5units) (Promega) and 10X kinases 
buffer (3^1) were added to the immunoprecipitated complexes. The kinase mixtures of 
PKA and PKC were supplemented with 100-200^M ofATP (3^1) (Sigma), while that of 
PKG was supplemented with 100-200^iM ofcGMP (3jal) (Sigma). The kinase reactions 
were incubated at 30�C for 1.5 hours. The reactions were stopped by adding 200^il of 
RJPA with phosphatase inhibitors Q)-nitrophenylphosphate, P-glycerolphosphate and 
sodium flouride). The exu protein anti-exu antibody complexe was collected by 
centrifligation at 4500g at 4�C for 5 minutes, and the complex was washed twice with 
0.5ml of ice-cold RIPA with phosphatase inhibitor. Finally，the phosphorylated protein 
complexes were resuspended in 20^il of 2X SDS sample buffer supplemented with lOmM 
EDTA，pH 8.0 and boiled for 5 minutes. The boiled samples were stored at -20°C. 
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4.2.2 Separation of the phosphorylated exu protein variants by SDS-
PAGE 
The phosphorylated exu protein constructs and the L-[^^] methionine labeled exu 
complexes were boiled for 5 minutes before being subjected to gel electrophoresis using 
a 10% SDS-polyacrylamide gel electrophoresis at 50mM constant current for 4.5 hours to 
5 hours. 
The proteins were transferred onto a nitrocellulose membrane (Schleicher& Schuell) and 
then air-dried. To visualize the phosphorylated exuperantia protein, the air-dried 
membrane was directly exposed to an X-ray film (X-Omat™ Blue XB-1, Kodak) with an 
intensifying screen (DuPont). To ascertain the identity of the radiolabelled protein, the 
membrane was probed with a rabbit polyclonal anti-exu antibody. 
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4.3 Results 
4.3.1 Western blot analysis of in vitro translated exu protein variants 
Westem blot of the wild type and mutated exu proteins were probed with a polyclonal 
rabbit anti-exu antibody (Figure 4.1). The exu proteins were produced by the TNT in 
vitro translation system. The exu proteins (lanes 2, 3，4, 5, and 6) can be detected in the 
Westem blot. The non-c-myc tagged exu protein variants (lanes 4 and 5) have the same 
molecular mass with the non-c-myc tagged wild type exu protein (lane2). The c-myc 
tagged exu protein variant (lane 6) has same molecular mass with the c-myc tagged wild 
type exu protein (lane 3). The size of the c-myc tagged exu protein variants (lanes 3 and 
6) are 2kDa (20 amino acid residues) greater than the non-c-myc tagged exu protein 
variants (lanes 2, 4 and 5). 
115 
Figure 4.1 Western blot of in vitro translated exu protein and different exu 
mutant constructs. Westem blot was probed with a polyclonal rabbit anti-exu antibody. 
Multiple isoforms of exu protein with different molecular weights can be detected in the 
wild type ovary extract. Lane exu'\ ovary extract of exu protein null mutant; lane w " � 
ovary extract of wild type; lane 1，in vitro translation product of pGEM-I vector; lane 2, 
in vitro translation product of p556; lane 3, in vitro translation product of p556-myc; lane 
4，in vitro translation product of p556-ES2; lane 5, in vitro translation product of p556-
ES3; lane 6, in vitro translation product of p556-myc-ES4. Both of the endogenous exu 
protein and the in vitro translated exu protein can be recognized by a polyclonal rabbit 
anti-exu antibody. Comparing lanes 1 and 2, the band in lane 2 was contribute by the exu 
cDNA insert in pGEM-I. Comparing lanes 2 and 3, the labeled exu protein in lane 3 has 
a higher molecular weight than the unlabeled exu protein in lane 2. 
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4.3.2 Phosphorylation of in vitro translated exuperanita protein 
variants by exogenous cAMP-dependent protein kinase 
The immunoprecipitated in vitro translated exuperantia protein variants were 
phosphorylated by exogenous PKA (Figure 4.2). The exu protein variants, wild type 
(lane 3), c-myc epitope tagged wild type exu protein (lane 5), ES2 (lane 7), ES3 (lane 9) 
and c-myc tagged ES4 (lane 11), were phosphorylated by PKA. Comparing the 
phosphorylation pattem of wild type exu protein (lane 3) with ES2 and ES3 mutant 
variants, they gave similar phosphorylation patterns and levels. The result suggested that 
ES2 and ES3 mutation on the exu protein did not change the PKA phosphorylation. 
Comparing the phosphorylation pattem of c-myc tagged wild type exu protein (lane5) 
with c-myc tagged ES4 mutant variant, they displayed similar phosphorylation pattem 
and level, suggesting that the ES4 mutation did not affect the PKA phosphoryaltion. 
Comparing the wild type exu protein (lane 3) and c-myc tagged wild type exu protein, 
they showed similar phosphorylation pattem but different phosphorylatation level, it was 
suggested that the c-myc epitope decrease the phosphorylation level on exu protein. 
In order to confirm the identity of the phosphoproteins, the protein blot was probed by a 
rabbit polyclonal anti-exu antibody as shown in Figure 4.3. The immunoreactive bands 
on the Westem blot and the radioactive bands on X-ray film gave same position. The 
phsophorylated bands of the autoradiogram were indeed exu protein based on the positive 
immunological reactivity. The results suggested that the bands on X-ray film are due to 
phosphorylation of exu proteins and the exu proteins were labeled with [^^P]-y-ATP. 
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Figure 4.2 Exogenous PKA phosphorylation assay on exu protein variants. 
In vitro phosphorylation assay of immunoprecipitated exu protein complexes by PKA. 
Lanes 1，3, 5, 7, 9 and 11，exu protein complexes were phosphorylated by PKA (+). 
Lanes 1 and 2, translation product of pGEM-I; lanes 3 and 4，translation products ofp556; 
lanes 5 and 6，translation products of p556-myc; lanes 7 and 8, the translation products of 
p556-ES2; lanes 9 and 10, translation products of p556-ES3; and lanes 11 and 12， 
translation products of p556-ES4. All the exu protein complexes can be phosphorylated 
by PKA with similar pattem. 
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Figure 4.3 Western blot of PKA phsophorylated exu protein varinats. 
Protein blot was probe with a polyclonal rabbit anti-exu antibody. Nearly equivalent | 
ji i 
amount of exu protein in each lane was loaded. Lanes 1，3, 5, 7, 9 and 11，exu proteins ^ 
were phsophorylated with PKA. Lanes 1 and 2, translation product ofpGEM-I; lanes 3 
and 4，translation products of p556; lanes 5 and 6, translation products of p556-myc; 
lanes 7 and 8，the translation products of p556-ES2; lanes 9 and 10，translation products 
ofp556-ES3, and lanes 11 and 12, translation products of p556-myc-ES4. The relative 
amount ofexu protein added can be estimated by comparing the intensities ofthe bands. 
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Comparing the amount of the wild type exu protein (lane 3) with that ofthe c-myc tagged 
wild type exu protein, it showed that the amount of non-c-myc tagged exu protein (lane3) 
was more than the c-myc tagged exu protein (lane 5). The result suggested that the 
different phosphorylation level on the c-myc tagged wild type exu protein was due to the 
different amount of the exu proteins loaded. Furthermore, this result also indicated that 
the same degree and level of phosphorylation by the PKA in different exu protein 
variants were not due to the differences in the amount ofprotein being loaded. 
To evaluate whether different amount of in vitro translated protein was used in 
phosphorylation assays, aliquots of in vitro translated exuperantia protein variants were 
directly labeled with L-[^^]methionine and therefore the amount of the exu protein 
variants added in each PKA phosphorylation reaction were normalized with respect to the 
L-[35s]methionine labeled exu proteins. The labeled exu protein variants were 
immunoprecipitated in the same conditions as those for the unlabeled exu protein. 
Therefore, the relative amount of the exu proteins added in each PKA phsophorylation 
reaction can be reflected by the relative amount of the labeled exu protein in each 
reaction. The labeled exuperantia proteins were separated under the SDS-PAGE and the 
proteins were transferred to a nitrocellulose membrane. The membrane was directly 
exposed to a X-ray film and the autoradiography image is shown in Figure 4.4. All the 
bands have the similar intensity. Therefore, it is suggested that equivalent amount ofexu 
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Figure 4.4 Western blot of L-[35s]methionine tagged exu protein variants. 
In vitro translated exu protein variants were directly labeled with L-[^^]methionine 
during translation reaction. Lane 1, translation product of pGEM-I; lane 2, translation 
product of p556; lane 3，translation product of p556-myc; lane 4，translation product of 
p556-ES2; lane 5, translation product of p556-ES3; and lane 6，translation product of 
p556-myc-ES4. The relative amount of exu protein added in each PKA phosphorylation 
reaction can be estimated by comparing the relative intensities of the bands. 
122 
4.3.3 Phsophorylation of in vitro translated exuperantia protein 
variants by exogenous cGMP-dependent protein kinase 
The exogenous PKG phosphorylation assay of the immunoprecipitated in vitro translated 
exuperantia protein complexes are shown in Figure 4.5. The exu protein constructs, wild 
type, c-myc epitope labeled exu protein, ES2, ES3 and c-myc tagged ES4, were labeled 
with PKG in lanes 3, 5, 7 9 and 11，respectively. Comparing the phosphorylation pattem 
of wild type exu protein (lane 3) with ES2 (lane 7) and ES3 (lane 9) protein variants, the 
results gave similar phosphorylation patterns and levels. The result suggested that the 
ES2 and ES3 mutations did not affect the PKG phosphorylation. Comparing the 
phosphorylation pattem of c-myc tagged wild type exu protein (lane 5) with c-myc 
tagged ES4 protein variant (labe 11), they displayed similar phosphorylation pattem and 
level, suggesting that the ES4 mutation did not affect the PKG phosphoryaltion on exu 
protein. Comparing the non-c-myc tagged wild type exu protein (lane 3) and the c~myc 
tagged wild type exu protein (lane 5), the results showed similar phosphorylation pattem 
and level, it was suggested that the PKG phosphorylation is not affected by the c-myc 
epitope tagging on exu protein. 
In order to confirm the identity of the phosphoproteins, the protein blot was probed by a 
rabbit polyclonal anti-exu antibody as shown in Figure 4.6. The immunoreactive bands 
on Westem blot and the radioactive bands on X-ray film gave same position. The 
phosphorylated bands of the X-ray film were indeed exu protein based on the positive 
immunological reactivity. The results suggests that the bands on X-ray film are due to 
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PKG phosphorylation on exu proteins and the proteins were labeled with [^^P]-y-ATP. 
The result indicated that the same level of PKG phosphorylation in different exu protein 
variants were not due to different amount of exu proteins being loaded. 
To evaluate whether different amount of in vitro translated protein was used for in vitro 
phosphorylation assay, aliquot of in vitro translated exuperantia protein variants were 
directly labeled with L-[^^S]methionine and therefore the amount of the exu protein 
variants added in each PKG phosphorylation reaction were normalized by the L-
:35s]methionine labeled exu proteins. The labeled exu protein variants 
immunoprecipitated in the same time with the unlabeled exu protein. Therefore, the 
amount of labeled exu protein is directly proportional to the amount of the unlabeled exu 
protein in each PKG phosphorylation. The labeled exuperantia proteins were separated 
by the SDS-PAGE and the proteins were transferred onto a nitrocellulose membrane. 
The membrane was directly exposed to a X-ray film and the autoradiography image is 
shown in Figure 4.7. All the bands have the similar intensity. Therefore, from each PKG 
phosphorylation reaction approximately the same amount of the exu protein 
immunoprecipitated complexes were loaded. 
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Figure 4.5 Exogenous PKG phosphorylation assay on exu protein varinats. 
In vitro phosphorylation assay of immunoprecipitated exu protein complexes by PKG. f 
Lanes 1，3，5，7，9 and 11，exu protein complexes were phosphorylated by PKG (+). 
Lanes 1 and 2, translation product of pGEM-I; lanes 3 and 4，translation products ofp556; 
lanes 5 and 6，translation products of p556-myc; lanes 7 and 8, the translation products of 
p556-ES2; lanes 9 and 10，translation products of p556-ES3; and lanes 11 and 12， 
translation products of p556-myc-ES4. All the exu protein complexes can be 
phosphorylated by PKG with similar pattem and level. 
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Figure 4.6 Western blot of PKG phsophorylated exu protein variants. 
Protein blot was probe with a polyclonal rabbit anti-exu antibody. Equivalent amount of 
exu protein in each lane were loaded. Lanes 1, 3，5, 7，9 and 11，exu proteins were 
phsophorylated by PKG. Lanes 1 and 2，translation product of pGEM-I; lanes 3 and 4， 
translation products of p556; lanes 5 and 6, translation products ofp556-myc; lanes 7 and 
8，the translation products of p556-ES2; lanes 9 and 10, translation products ofp556-ES3, 
and lanes 11 and 12, translation products of p556-myc-ES4. The relative amount ofexu 
protein added can be estimated. 
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Figure 4.7 Western blot of L-[^]methionine labeled exu protein variants. 
/« vitro translated exu protein variants were directly labeled with L-[^^]methionine 
during translation reaction. Lane 1, translation product of pGEM-I; lane 2, translation 
product of p556; lane 3，translation product of p556-myc; lane 4, translation product of 
p556-ES2; lane 5, translation product of p556-ES3; and lane 6, translation product of 
p556-myc-ES4. The relative amount of exu protein added in each PKG phosphorylation 
reaction can be estimated. 
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4.3.4 Phosphorylation of in vitro translated exuperanita protein 
variants by exogenous protein kinase C 
The immunoprecipitated exu protein complexes were phosphorylated by exogenous PKC 
(Figure 4.8). The exu protein constructs, wild type, c-myc epitope labeled exu protein, 
ES2, ES3 and c-myc tagged ES4, were phosphorylated by PKC as shown in lanes 3，5, 7 
9 and 11，respectively. Comparing the phosphorylation patterns ofwild type exu protein 
(lane 3) with those of ES2 (lane 7) and ES3 (lane 9) protein variants, they gave similar 
phosphorylation patterns and levels. The result suggested that the ES2 and ES3 mutation 
did not change the PKC phosphorylation reaction on exu protein. Comparing the 
phosphorylation pattem of c-myc tagged wild type exu protein (lane 5) with that ofc-myc 
tagged ES4 protein variants (lane 11)，they displayed similar phosphorylation pattem and 
level, suggesting that the ES4 mutation did not affect the PKC phosphoryaltion reaction. 
In order to confirm the identity of the phosphoproteins, the protein blot was probed by 
using a rabbit polyclonal anti-exu antibody as shown in Figure 4.9. The immunoreactive 
bands on Westem blot and the radioactive bands on X-ray film gave same location. The 
phsophorylated bands ofthe autoradiogram were indeed exu protein based on the positive 
immunological reactivity. It shows that the bands on the X-ray film are due to 
phosphorylation of exu proteins and labeled with radioactive phosphate group. All the 
bands on the autoradiogram have similar intensity. The result showing that same amount 
of the exu protein complexes were loaded in each lane. Furthermore, this result also 
showed that same degree of phosphorylation by PKC in different exu protein constructs 
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Figure 4.8 Exogenous PKC phosphorylation assay on exu protein variants. 
In vitro phosphorylation assay of immunoprecipitated exu protein complexes by PKC. 
Lanes 1，3, 5，7, 9 and 11, exu protein complexes were phosphorylated by PKC (+). 
Lanes 1 and 2, translation product of pGEM-I; lanes 3 and 4，translation products of p556; 
lanes 5 and 6, translation products of p556-myc; lanes 7 and 8, the translation products of 
p556-ES2; lanes 9 and 10，translation products of p556-ES3; and lanes 11 and 12, 
translation products of p556-myc-ES4. All the exu protein complexes can be 
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Figure 4.9 Western blot of PKC phsophorylated exu protein varinats. 
Nitrocellulose blot was probed with a polyclonal rabbit anti-exu antibody. Equivalent 
amount of exu proteins in each lane were loaded. Lanes 1，3, 5，7，9 and 11，exu proteins 
were phsophorylated by PKC. Lanes 1 and 2，translation product ofpGEM-I; lanes 3 and 
4, translation products of p556; lanes 5 and 6，translation products of p556-myc; lanes 7 
and 8，the translation products of p556-ES2; lanes 9 and 10, translation products of p556-
ES3, and lanes 11 and 12，translation products of p556-myc-ES4. The relative amount of 
exu protein added can be estimated. 
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were not due to the differences in the amount of protein being loaded. 
To evaluate whether different amount of in vitro translated protein was used for in vitro 
phosphorylation assay, aliquot of directly labeled with L-[^^]methionine in vitro 
translated exuperantia protein constructs were separated by SDS-PAGE and directly 
visualized by autoradiography (Figure 4.10). The signals of the bands on the X-ray are 
directly proportional to the amounts of the exu protein complexes added in each PKC 
phosphorylation reactions. All the bands on the X-ray film have the same level signal. It 
shows that same amount of the exu protein complexes were applied in each PKC 
phosphorylation reactions. 
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Figure 4.10 Western blot of L-[''S]methionine labeled exu protein variants. 
/« vitro translated exu protein variants were directly labeled with L-[^^]methionine 
during translation reaction. Lane 1, translation product of pGEM-I; lane 2, translation 
product of p556; lane 3，translation product p556-myc; lane 4，translation product of 
p556-ES2; lane 5, translation product of p556-ES3; and lane 6，translation product of 
p556-myc-ES4. The relative amount of exu protein added in each PKC phosphorylation 
reaction can be estimated. 
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4.4 Discussion 
The aim of in vitro phosphorylation experiment is to identify the putative 
phosphorylation site(s) of exu protein. The exu protein constructs were phosphorylated 
with protein kinases. If a putative phosphorylation site of the exu protein variants were 
removed by site-directed mutagenesis, the pattem and level of phosphorylation on the 
protein should be changed. 
The phosphorylation sites of exu protein are serine and theronine predominantly. The 
recombinant exu protein can be phosphorylated by PKA, PKC and PKG but not glycogen 
synthease kinase-3 (GSK-3), casein kinase I (CK I) and casein kinase II (CK II) (Cheung, 
1997). In addition, she found that localization of exu protein at stage 7 of PKA' 
deficiency mutant oocytes was altered. It suggests that PKA appears to play a key role in 
maintaining the localization of exu protein. Therefore, the serine and theronine specific 
protein kinases (PKA, PKC and PKG) were used in the in vitro phosphorylation assay. 
The exogenous protein kinases, PKA catalytic subunit (Promega), PKG-a isoenzyme 
(Promega) and PKC catalytic subunit (Calbiochem), are used in the in vitro 
phosphorylation experiments. The PKA catalytic subunit is isolated from bovine heart 
tissue, the PKG a isoenzyme from bovine lung tissue and the PKC catalytic subunit 
from rat brain tissue. 
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These mammalian kinases were chosen because the biochemical properties ofvertebrate 
PKA catalytic subunit are similar to that ofDrosophila and there high degree ofsequence 
similarity between the homologous PKA subunit (Hardie and Hank, 1995). The PKG a 
isoenzyme kinase domians of bovine lung is 70% and 75% identical to the Drosophila 
PKG DG1 and DG2 subunit respectively (Hardie and Hank, 1995). The PKC of 
Drosophila has a extensive homology with the PKC of rat PKC (Rosenthal A，et al., 
1997). 
Li the phosphorylation assay, the exu protein constructs (ES2, ES3 and ES4) were 
phosphorylated by the exogenous PKA, PKC and PKG. The pattem and level of 
phosphorylation by PKA, PKC and PKG on various exu protein variants did not have any 
significant difference when compared with that ofwild type exu protein. 
The negative results of the phosphorylation assay may be due to several reasons. Firstly, 
the ES2, ES3 and ES4 amino acids residues are not the phosphorylation sites of the exu 
protein. Secondly, the conditions of the exogenous kinases system are different from 
those ofthe in vivo conditions. The non-phosphorylated amino acids residues were non-
specifically phosphorylated by the exogenous kinases. 
Although the in vitro experiment have some limitation, it is still a good and fast method 
to identify the putative phosphorylation site(s) on the exu protein. If the putative 
phosphorylation site of exu protein is removed, the phosphorylation will change 
134 
dramatically. The changing of the phosphorylation pattem and level could be examined 
by Westem blots. 
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CHAPTER 5 Introduction of the exuperantia genomic mutant 
constructs into germline of Drosophila by P-element 
mediated transformation 
5.1 Introduction 
The mis-localization of bcd mRNA in the exu mutant oocyte shows the relationship 
between exu and bcd. For example, in exu mutants, distribution ofbcd mRNA is affected. 
However, in bcd mutants, exu protein distribution is not affected. These results 
suggested that exu is an upstream regulator of bcd mRNA localization. However, the 
control mechanism of exu protein acting on the bcd mRNA localization at the anterior 
pole ofDrosophila embryos is still unknown. 
Post-translation modification is a common mechanism that modulates the function of a 
protein. The post-translation modifications include acetylation, methylation, 
glycosylation, sulfation, ribosylation, prenylation and phosphorylation. In the pervious 
study，we have shown that phosphorylation of exu protein is pre-dominant on serine and 
theronine residues and the localization of exu protein is affected in the PKA mutants 
(Cheung, 1997). A transgenic fly was generated in order to evaluate the physiological 
function of phosphorylation on the exu protein. 
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The exu mutant constructs were generated by the Sculptor mutagenesis system. The exu 
mutants constructs was cloned into pCaSpeR transforming vector ofDrosophila, and then 
introduced into the germline of Drosophila by P element-mediated transformation (Rubin 
and Spradling, 1982; Spradling and Rubin, 1982). The pCaSpeR vector is a modified P 
element vector and it is optimized for the Drosophila transformation (Pirrotta, 1988). 
The pCaSpeR vector contains a visible marker gQUQ-white gene which gives a red-eyed 
phenotype for easy identification of the transgenic flies from the injected flies. The 
insertion of P element into the genome of an organism is an autonomous reaction. The 
size of the interested gene cannot be up to 54kb. However, the pCaSpeR vector is a 
defective P-element that it can not autonomously insert into the genome of an organism. 
A helper DNA plasmid which encodes a transposase should be co-injected with the 
pCaSpeR-exw transforming vector into Drosophila embryos. The P element containing 
the interested DNA fragment will "jump" into the genome ofDrosophila with the help of 
the transposase. 
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5.2 Materials and methods 
5.2.1 Construction of a genomic construct for production of 
transgenic flies 
The pCaSpeR vector containing wild type exu genomic DNA with 3, and 5, UTR Q)C1) 
was used in the Drosophila transformation (Figure 5.1). The Xba I fragments with the 
mutations were subcloned into the pCl by directional cloning (Figure 5.2). 
The transforming vector with the ES mutation were injected into the Drosophila eggs by 
micro-injection. The injected embryos were grown on slides until the embryos developed 
to larvae. The larvae was transferred to a vial containing the standard yeast-commeal-
agar media. The injectees (GO) were crossed with white. Drosophila. As red-eye 
phenotype is coming from the white gene on the pCaSpeR vector, the offspring of the 
injectees (G1) with red-eyes phenotype was picked. Moreover, the chromosomal 
location ofthe transgenic exu was tested by segregation. The transgenic flies containing 
細 transgenic on the third chromosome are preferred. It is because exu is located on the 
second chromosome. The transgenic exu on the third chromosome are easily established 
in the exu mutant background by genetic crosses. Finally, the localizations and 
phosphorylation patterns of exu protein in exu mutant was studied. 
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Figure 5.1 Genetic map of pCl 
The pCaSpeR vector containing exu genomic DNA sequence with 5'UTR and 3，UTR is 
called pCL The white gene on the pCaSpeR vector is a marker gene. The gene encodes 
a red-eyes phenotype. The eye color of the injectee is white. The progenies of the 
injectee with the red-eyes phenotype are transformed with the pCl plasmid. The 
transgenic flies can be easily identified by red-eyed phenotype. Three DNA fragments 
(0.86kb, 2.5kb and 10.9kb) were generated from pCl Sal I digestion. One ofthe Sal I 
restriction located at the exu and the others located at the pCaSpeR vector. The 
orientation ofthe exu in the pCl plasmid can be confirmed by restriction mapping. 
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Figure 5.2 Schematic diagram of the subcloning of pCl with the exu mutations. 
Panel A is the genetic map of pCl containing ES1, ES2 or ES3 mutations. The mutated 
Xba VHind III fragments were derived from the digestion of the pl001 plasmid with ES1, 
ES2 or ES3 mutations. The Hind IIL'P5/1 and Pst VXba I fragments were derived from 
the wild type exu. Finally, the three DNA fragments were ligated with the Xba I digested 
pCl vector. Panel B is the genetic map of pCl containing ES4 or ES5 mutations. The 
mutated Bgl lHPst I fragments were derived from the PCR of the pl003 plasmid with 
ES4 or ES5 mutations. The Xba VBgl II and Pst VXba I fragment were derived from the 
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5.2.2Preparation ofdouble-stranded DNA by ultra-centrifugation 
The DNA plasmid was prepared according to the polyethylene glycol DNA precipitation 
method as described in Chapter two, Section 2.2.1.1. Isopropanol precipitated DNA 
pellet was resuspended in 4.56ml TE. The DNA solution was mixed with 4.95g cesium 
chloride and 396p,l of lOmg/ml ethidium bromide, then loaded into a 4.9ml (13X48mm) 
Beckman OptiSeal™ polyallomer centrifuge tube with a pasteur pipette. The DNA 
solution was centrifugation at 65000 rpm for 4.5 hours at 20�C in a NVT 65.2 rotor in 
Beckman L-7 ultracentrifuge. The DNA was visualized under long wavelength UV lamp, 
and the supercoil DNA band was removed with a 3ml plastic syringe. The DNA was 
transferred to a 1.5ml micro-centrifiige tube. The ethidium bromide was extracted by 
mixing equal volume of water-saturated butanol for several times until all the ethidium 
bromide was removed. The DNA was diluted with two volumes of double-distilled water 
and precipitated by 0.1 volume 3M pH 5.2 sodium acetate and 2 volume of absolute 
ethanol at -70°C for 60 minutes. The DNA was pelleted by centrifugation at 13000 rpm 
in a table-top centrifuge. The DNA pellet was washed by 1ml 70% ethanol and air-dired. 
The DNA pellet was resuspended in lOO i^l ofTE. 
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5.2.3 P-element mediated transformation 
5.2.3.1 Eggs collection 
The flies were placed in a small collection bottle. The eggs were laid on an apple juice 
agar plate. The eggs and yeast were collected from the surface of the medium using a 
paint-brush. The dead flies were removed from the eggs and yeast suspension by a 
plastic household sieve. The eggs were collected from the suspension with a second 
sieve. The eggs were washed three times to remove the yeast cells. 
5.2.3.2 Dechorinating the eggs 
The eggs were shoak in a 5% sodium hypochloride (undiluted household chlorox) for 
about two minutes and then washed with sterile double-distilled water for several times in 
order to remove the sodium hypochlorite. Then the eggs were transferred onto a slide 
with double-sided sticky tape (3MM) and lined up in correct orientation. The eggs were 
desiccated by anhydrous calcium phosphate in a desiccator for approximately twenty 
minutes. The eggs were covered with a layer of halocarbon oil to prevent further 
desiccation. 
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5.2.3.3 Orientating the eggs 
The eggs were orientated so that the posterior pole was aligned toward an edge o fa slide 
(Figure 5.3). The posterior cells of the eggs will form the germ cells or pole cells. 
Therefore, injection ofDNA at the posterior end of the eggs increased the chance ofgerm 
line transformation. 
DNA 
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Figure 5.3 Eggs orientation on the sUde 
The posterior poles of eggs were facing the edge of a slide for recognization. The 
anterior pole is the most tapering and carries the small outgrowth of the micropyle (the 
site of sperm entry). The ventral surface of the egg is convex. The DNA was injected at 
the posterior pole of the embryo by microinjection. 
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5.2.3.4 Microinjection 
The DNA was loaded into the micropipette by capillary action. The first egg was brought 
into the field of vision and focus on the peripheral surface. Lower the needle such that 
the tip is in focus and gently touch the egg with the tip. This tests the turgor of the 
vitelline membrane and degree of desiccation. Moreover, care must be taken so that the 
micropipette is at the right level and it will not slip across the surface of the egg. The 
micropipette was penetrated into the vitelline membrane. However, it should be 
confirmed that no leakage and funneling should occur. Then the DNA was injected into 
the posterior pole of the embryos. The needle was removed carefully. The next egg was 
brought into the field and continued the injection. After injection, the slides were placed 
into a Petri dish and that the eggs were sufficiently covered with halocarbon oil. The 
embryos were incubated at 18�C for about 2 days. The injected survived larvae were 
transferred to a vial with standard yeast-commeal-agar fly food and incubated at 23�C for 
about 2 weeks. 
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5.2.4 Collection of virgin female Drosophila 
After mating, the female fly stores sperm in the ventral receptacle and spermstheca, and 
these stored sperms are sufficient to allow females to lay fertile eggs for many days. 
Therefore, virgin female Drosophila is necessary for the crossing experiment. 
The routine for collecting virgins is to tip off all flies firstly in the moming and then to 
collect and separate the flies into sexes that emerge in the next 8 hours, since flies will 
not mate for up to 8 hours after eclosion under normal conditions. The virgins were 
transferred to a vial containing fly food and incubated at 25�C. 
5.2.5 Setting-up a crossing experiment 
The virgin females were crossed with males in a vial containing fly food. The ratio of 
virgin females to males was five to one. The flies were kept at 25�C and flies were 
transferred to a new vial daily. 
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5.2.6 Preparation of total ovaries or testes extracts from female and 
male Drosophila 
Ovaries and testes were isolated from two-day-old Drosophila. The ovaries and testis are 
dissected in phosphate buffered saline (PBS) (8g NaCl, 0.2g KC1, 1.44g NaHPO4 and 
0.24g KH2PO4 in lL of double-distilled water, adjusted to pH 7.4 with HC1). The 
dissected ovaries and testes were washed with 125mM Tris-HCl, pH 6.8 and then 
homogenized in a 2X SDS sample buffer (62.5mM Tris-HCl, pH 6.8, 2% SDS，5% 
mercaptoethanol, 10% glycerol, 0.005% bromophenol blue) in a ratio ofone pair ofovary 
or testis to lOp,l of2X sample buffer. The samples were boiled for 5 minutes and stored 
at -20°C. The presence of exu protein was probed with a rabbit polyclonal anti-exu 
antibody. 
5.2.7 lmmunohistochemical distribution of exuperantia protein 
yW flies were used as the wild type control, exu^ s2.1 ^^s an exu mutant, and exn '^ was an 
exuperantia protein null mutant which was used as the negative control. The 
immunohistochemical protocol was esssentially as described by Macdonald et aL,l99l 
with modification. 
About 20 pairs of ovaries from two-day-old flies were dissected in PBS. The ovaries 
were dispersed by pipetting up and down with a volume of 30^1 (pipette volume) in about 
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50jil (total PBS volume) ofPBS until the individual ovarioles were completely dispersed 
in PBS. Excessive pumping was avoided as it could destroy the morphology ofovarioles. 
The ovarioles were incubated in 1ml 0.375M KC1 in PBS at 37�C for 30 minutes. Then, 
the ovarioles were washed twice with PBS. The ovarioles were fixed in 4% 
formaldehyde in PEM buffer (lmM EGTA, 2mM MgSO4, and O.lM Pipes) at room 
temperature for 17 minutes with rotation. 
After fixation, the ovarioles were rinsed twice briefly with PTW (0.1 % Tween 20 in 
PBS), and then washed twice with PTW for 30 minutes. The ovarioles were incubated 
with a primary polyclonal rabbit anti-exu antibody with (1:1600 dilution) in TNBTT 
buffer (0.1 % BSA, 150mM NaCl, 0.05% thimerosal, 50mM Tris-HCl，pH 7.5，0.1% and 
Triton X-100) at 4°C ovemight with rotation. The ovarioles were washed twice with 
TNBTT for 5 minutes to remove the unbound primary rabbit anti-exu antibody. The 
ovarioles were incubated in 2% normal goat serum in TNBTT for 30 minutes in order to 
minimize the non-specific binding of secondary goat anti-rabbit antibody. The ovarioles 
were washed twice with TNBTT containing 1% BSA. The higher BSA concentration in 
TNBTT was used in the washing in order to minimize staining background. 
The ovarioles were incubated for 2 hours with monoclonal goat anti-rabbit antibody 
conjugated with Rhodamine Red X (Molecular Probe). The secondary antibody was 
diluted 600 fold in TNBTT. The ovarioles were washed twice each for 5 minutes with 
PTW in order to remove the unbound secondary antibody. Finally，the ovarioles were 
mounted in a mounting medium (2.3% (w/v) of l,4-diazabicyclo-[2,2,2,]-octane 
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(DABCO), 90% glycerol, O.lM Tris-HCl, pH 8.0 and 0.02% azide), and observed under a 
Zeiss Axiophot microscope using a 40X Plan-Neoflur objective equipped with 
epifluorescence optics. The fluorescence images of the ovarioles were captured by 
Photometrix SenSys cooled-CCD camera. The digitized fluorescence images were 
processed with MetaMorph imaging software, and the images were assembled with the 
aid of Photoshop 5.0(Adobe). The images were printed out with Kodak film using a 
Kodak 8650 PS colorprinter. 
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5.3 Results 
5.3.1 Insertion of the mutated exu fragments into the Drosophila 
transforming vector (pCaSpeR). 
The mutated exu fragment was subcloned into the pCl vector (pCaSpeR vector contains 
exu genomic DNA sequence). The exu fragments with the ES1 or ES2 mutation were 
successfully subcloned into the pCl plasmids (Figure 5.4). The DNA sequences of the 
ES1 and ES2 mutations on the pCl-ESl and pCl-ES2 plasmids were confirmed by 
dideoxy DNA sequencing (data not known). 
The orientation of the exu fragment inserted into pCl vector was confirmed by restriction 
mapping. Results of the agarose gel electrophoresis of the Sal I digested pCl, pCl-ES2 
and pCl-ES2 were shown in Figure 5.4. The pCl plasmid contains three Sal I restriction 
sites. The total molecular size of the plasimd is about 14kb. The Sal I digested pCl 
plasmid generated three restriction fragments (10.9kb, 2.5kb and 0.86kb). Since there 
was only one nucleotide change in pCl-ESl and pCl-ES2 when compared with the pCl, 
therefore the Sal I digested pCl-ESl and pCl-ES2 should give similar fragments sizes if 









Figure 5.4 Genetic maps and RFLP of the Sal I digested pCl, pCl-ESl and pCl- ！ 
ES2 plasmids. The pCl, pCl-ESl and pCl-ES3 plasimds were digested with the Sal I ！ 
restriction enzyme. Lane M, the X DNA Hind III marker; lane 1, pCl plasimd digested 
with Sal I; lane 2, pCl-ESl plasmid digested with Sal I; and lane 3，pCl-ES2 plasmid 
digested with Sal 1. Lanes 1, 2，and 3, and the plasmids were digested with Sal I and 
generated three restriction fragments (10.9kb, 2.5kb and 0.86kb). Comparing the sizes of 
the fragments in lanes 1，2 and 3, all of them have the same sized fragments. It suggests 
that the Xba I fragment ofpCl-ESl and pCl-ES2 have the same orientation of pCl. 
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5.3.2 Introduction of the mutated exu gene into the genome of 
Drosophila by P-element mediated transformation 
Micro-injection and the segregation test experiments were kindly done by Dr. Tony Ip, 
Program in Molecular Medicine, University of Massachusetts Medical School, 55 Lake 
Avenue North, Worcester, MA., USA. 
The exu fragments with the ES1 and ES2 mutations were sub-cloned into the pCaSpeR 
vector with the exu gneomic DNA (Figure 5.5). The injected pCl-ESl and pCl-ES2 
plasmids were prepared by ultra-centrifugation in order to get high quality DNA. Then 
the pCl-ESl and pCl-ES2 plasmids were injected into the Drosophila embryos together 
with the helper DNA. Two lines oftransgeneic flies (ES2.1 and ES2.2) containing the 
ES2 mutations were obtained. 
The P element-mediated formation is an autonomous process. The chromosomal location 
ofthe transgenic exu in the genome ofDrosophila cannot be predicted. Since the location 
of the transgenic exu is an important information，the location of the transgenic exu was 
determined by the segregation test (Figure 5.5). 
Before the assay, wild type exu gene in the transgenic flies (ES2) were removed by the 
segregation cross with the exu null mutant flies. The wild type exu gene and the exu 
(exu"c) null mutant are located on the second chromosome, and therefore the transgenic 
• location on the third or other chromosome is preferred. The exu^ ^^ -^  construct was 
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used to study the exu protein phosphorylation and immunohistolocalization of exu 
protein. 
The injectee (GO) were crossed with wild type flies. The progeny (G1) of the GO flies 
with the red-eyed phenotype were picked. The red-eyed phenotypes indicated that the GO 
flies were transformed with the pCl plasmid which conatins the white gene. 
The red-eyed G1 males were crossed with the virgin females with double balancers 
(yw/yw;BcElP/CyO;Ki/TM6y0. The BCElP, CyO, Ki and TM6y+ are balancer and 
marker chromosomes that carry visible-marker. For example, CyO is a balancer on the 
second chromosome and gives a curly-winged phenotype. On the other hand, if the 
transgenic exu is located on the X chromosome, all the G2 female progenies will be red-
eyed or all the G2 male progenies will be white-eyed. In contrast, if the transgenic exu is 
located on the Y chromosome, all the G2 male progeny will be red-eyed or all the G2 
female progenies will be white eyed. If the transgenic exu is located on the first, second 
or third chromosome, both G2 males and females progeny will be red-eyed. The flies 
with the transgenic exu located on the first, second or third were picked. 
The red-eyed, curly-winged and TM6y+ males (G2) were crossed with the wild type 
virgin females. If the transgenic exu is located on the second chromosome, all the red-
eyed flies will be straight-winged. It is because the transgenic exu is located on the same 
chromosome of the CyO, either the transgenic exu or the CyO was passing to the G3 
progeny. If the transgenic exu located on the third chromosome, all the red-eyed flies 
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will be without the phenotype ofTM6y+. It is because the transgenic exu is located at the 
same chromosome of the TM6y+，either the transgenic exu or the TM6y+ was passed into 
the G3 progeny. The flies with the trasngenic exu located on the third chromosome 
[exu^s2,i) were selected for further experiments. 
Before the immunostaning and kinase assay, the wild type exu gene in the exf! 
transgenic flies were replaced by a protien null allele by genetic crosses. The e x P ! 
males were crossed with the virgin females (yw/yw; BCElP/CyO; Ki/TM6y+) (Figure 
5.6). Meanwhile, the exu null (+/+; exu/CyO; +/+) males were also crossed with the 
virgin females (yw/yw; BCElP/CyO; Ki/TM6y+) (Figure 5.6). These crosses put the 
balancers on the transgenic flies. The virgin female progenies (G1-1) ofthe former cross 
with the red-eyed, TM6y+ and CyO phenotypes were picked. The male progenies (Gl-2) 
ofthe later cross with the red-eyed, no CyO (straight-winged) and TM6y+ were picked. 
The males (Gl-2) were crossed with the virgin females (G1-1). The progeny (G2) males 
and females with the red-eyed, CyO and TM6y+ were picked. The G2 males and G2 
virgin females were crossed. The males and virgin female of G3 progeny with the red-
eyed and CyO but no TM6y+ were kept as a stock. These flies have two copies of P 
element (ES2) on the third chromosome and one copy of exu on the second chromosome. 
The G4 progenies with the white-eyed and straight-winged 
(yw;exu/exu;P[ES2.1]yT[ES2.1]) were used for the immunostaining and the kinase assay. 
It is because these G4 flies produce exu proteins only from the ES2.1 chromosome, but 
not from the exu""" chromosome. 
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Figure 5.5 Segregation tests of the transgene exu in the transgeneic flies 
The injectee (GO) males or virgin females were crossed with the wild type virgin females 
or males respectively. The red-eyed G1 males (P[ES2]Af;+;+) were crossed with the 
virgin females with double balancer (yw/yw;BCElP/CyO;Ki/TM6y+) in oder to mark 
every chromosome. If P element is on X chromosome, either all the female G2 are red-
eyed or all the male G2 are white-eyed. If P element is on second or third chromosome, 
both male and female offspring may have the red eyes. The G2 males (yw; 
P[ES2]/CyO;TM6y+) with the P element in either second or third chromosome were 
crossed with the virgin females (null white gene background). If P is on second 
chromosome, all the red-eyed G3 flies are straight wings. If the P element on third 
chromosome, all the red-eyed G3 flies are TM6y+ deficiency. The G3 flies with the P 
element on the third chromosome were picked and crossed to null exu background. 
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Figure 5.6 Remove the endogenous exu in the ES2 transgeneic fly 
The males of exu null mutant (+;exu/CyO;+/+) crossed with the virgin female 
(yw/yw;BCElP/CyO;Ki/TM6y+). The males with the P element (yw;+/+;P[ES2]/+) on the 
third chromosome crossed with the virgin female (yw/yw;BCElP/CyO;Ki/TM6y+). The 
Gl-2 males with TM6y+ and BCElP were crossed with the Gl-1 virgin females with CyO; 
TM6y+ and P[ES2]. The G2 males and virgin females with P[ES2], TM6y+, CyO and no 
BCElP were crossed. The G3 flies with the red-eyed (P[ES2]) and CyO but no TM6y+ 
were kept at a stock. The G4 flies with the white-eyed and straight (no CyO) were used 
to carry out the immunostaning and kinase assay that these G4 flies with two copies of 
the P[ES2] and homozygous of the exu. 
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5.3.3Western blot analysis of the exu protein in the exu (ES2.1) 
transgenic fly 
A Westem blot analysis of exu protein in ovary and testis extracts ofthe flies was shown 
in Figure 5.7. The Westem blot was probed with rabbit polyclonal anti-exu antibody. 
Several discrete bands from both ovary and testis can be resolved by SDS-PAGE. The 
discrete bands are due to the different phosphorylated form of exu protein and this 
observation was confirmed by the exu protein dephosphorylated experiment. The bands 
can be divided into two major groups, hyperphosphorylated forms and 
hypophosphorylated forms characterized by lower mobility and higher mobility, 
respecitvely. The exu protein phosphorylated pattem ofwild types and the e x F ! ovary 
extracts are similar. But the exu protein phosphorylated pattem of wild types and the 
j^^2 j 
exw . testes extracts have some differences. It is noted that, the hyperphosphorylated 
forms ofthe exu protein from the exu^ ^^ -^  testis extract are less than that offrom wild type 
samples. 
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F^ure 5.7 Western blot analysis of exu protein in the exu s^2.1 transgeneic flies. 
Westem blot was probed with a rabbit polyclonal anti-exu antibody. Lane M，protein 
markers; lanes 1 and 5，ovary and testis extracts of homozygous exyf' female and male, 
respectively; lanes 2 and 6，ovary and testis extracts of w " " female and male, 
respectively; lanes 3 and 7，ovary and testis extracts ofyw female and male, respectively; 
lanes 4 and 8，ovary and testis extracts of homozygous e x f ! female and male, 
respectively. The band pattem in exu^ ^^ -^  from testis was different from that ofwild type. 
The hyperphosphorylated form of the exu protein in homozygous exi/^ -^^  testis extracts 
was decreased. 
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5.3.4 lmmunohistochemical distribution of exu protein in exu^ ^^ -^  
mutants 
lmmunohistochemical analysis of the distribution of exu protein was shown in Figure 5.8. 
The exu protein distribution in the previtellogenic chamber (Figure 5.8A and 5.8B) 
€叉严1 mutants and wild type was similar. Comparison of vitellogenic chamber (Figure 
5.8C and 5.8D) showed that the localization of exu protein in the e x f � mutants, was 
similar to those ofthe wild type vitellogenic egg chambers, exu protein was localized at 
the anterior margin ofthe developing oocyte. Comparison oflate stage chambers (Figure 
5.8E and 5.8F) showed that the exu protein distribution in the exu^ ^^ -^  mutants was similar 
to those ofthe wild type in stage 10 egg chambers, exu protein was evenly distributed in 
the nurse cell cytoplasm with the punctate structure at the margin ofthe nurse cell. The 
punctate structure may represent the ribouncleoprotein (RNP) particles as suggested by 
Wang and Hazelrigg, (1994). 
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r i 
Figure 5.8 Immunohistochemical distribution of exu protien in exu s^2J mutants 
In panel A，C and E, ovaries staining from yw, in panel B，D and F, ovaries staining from 
exuES2 i mutant. Panel A and B; previtellogenic stage; panel C and D: vitellogenic stage; « 
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5.3.5Rescue test of exu^ ^^ -^  trangenic flies 
As for a change in the phosphorylation pattem was observed in testes extract, fertility of 
transgenic flies were examined by rescue test and male fertility test. The e x P ! mutant 
constructs were tested for ability to rescue the exu'' matemal-effect lethality. The exu"' 
allele has a nonsense mutation on the predicted exu protein sequence at amino acids 53 
(Macdonald et al., 1991). The nonsense mutation causes the premature termination of 
translation and thus an exu protein null mutation. The eggs of homozygous exu"' 
background are nonviable and cannot emerge as viable adults. The males ofhomozygous 
exr/c background cannot produced functional sperm (Hazelrigg et al.’ 1990). 
Virgin females of the genotype exi^ V exi^'',鳴圓丨 ^ES2.i ^^^^ crossed to wild type 
males {yw) to test for rescue of the exy"' females matemal-effect lethality. The virgin 
females (exw^") were able to rescue the exy"' matemal-effect lethality, indicating that the 
female e x ^ ! retained the full activity ofthe wild type exu. 
Virgin wild type female were crossed to males of the genotype exy^ V exi^ \^ exif^^- l^ 
細删 to test for rescue of the exu"' males fertiltiy. The males (exu^ ^^ -^ ) were able to 
rescue the exu"' phenotype. It is suggested that the male e x P ! retained the activity of 
the wild type exu. 
Hence，number ofES2 progeny was examined by a male sterility test in which one ES2 
male transgenic fly crossed with five wild type females. The results showed that the 
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number of ES2 progeny decreased about 9% (number of progeny in single cross:- wild 
1 
I type: 142+22, n=16 cross vs ES2: 131+17, n=13 cross; p<0.04) (Figure 5.9). These 
results suggest that phosphorylation of exu protein is different in male and female, and it 
is required for the normal functions of exu. 
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Figure 5.9 Scatter plot of the number of progeny given out from the male 
steriKty test. The y-axis represented the number ofprogeny given out from a cross. For 
the male sterility test cross, one wild type or homozygous exu^ ^^ -^  male was crossed to 
five wild type females. The number of the progenies are 142± 22, n=16 (wild type) and 
131+17, n=13�exT/s2j~) withp<0.04. 
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5.4 Discussion 
The exu genomic constructs (ES1, ES2, ES3, ES4 and ES5) were generated by the 
Sculptor site-directed mutagenesis system. The mutants constructs cannot directly 
transformed into the genome ofDrosophila. The mutant constructs were introduced into 
the genome of Drososphila by P element-mediated transformation. The constructs were 
inserted into a Drosophila transformation vector containing 5'UTR and 3,UTR of exu 
genomic DNA sequence ^>C1). The exu genomic constructs (ES1 and ES2) were 
successfully subcloned into the pCl plasmid. 
« 
The subcloning of exu genomic constructs into pCl is quite difficult. It is because exu 
gene has not any "suitable" restriction sites for a simple subcloning. The coding region 
of the exu constrcuts were digested into three fragments (Xba VHind III，Hind llVPst I， 
Pst VXba I). All the fragments were ligated with the Xba I digested pCl vector at the 
same time. The pCl vector is the pUC18 plasmid containing the Drosophila P element, 
•te gene (Pirrotta, 1988) and exu genomic sequence, having final molecular size of 
about 14kb and therefore the cloning efficient is quite low. 
Two mutagenesis systems have been used in this study. The GeneEditor™ site-directed 
mutagenesis gave a simpler manipulation than the Sculptor™ site-directed mutagenesis. 
It is because that the p552 and p556 plasmids can be directly used in the GeneEditor™ 
mutagenesis reaction and thus the complicated subcloning procedures can be avoided. 
Hence, GeneEditor™ system was adapted for mutagenesis in the later studies. 
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For the rescue test, the e x f ! virgin females and males can restore the exu'' phenotype in 
males and females respectively. It is suggested that the exu^ allele has an exu function 
and it is not lethal. 
The localization of the transgenic exu protein (ES2.1) was visualized by the 
immunofloursecnce staining using anti-exu antibody. The localization pattem of exu 
protein in wild type and exu^ i were similar and no significant different. The result of 
staining agreed with that of the Westem blot analysis suggesting that effect of the ES2 
mutation on exu protein phosphorylation is not significant during oogenesis. 
The phosphorylation pattem of transgenic exu protein in the ovary is similar to the wild 
type. In constrast, the phosphorylation patterns of transgenic exu (ES2.1) protein is 
different with the wild type exu protein in the testes extract. It is noted that, the 
hyperphosphorylated bands of the transgenic exu protein is reduced when compared with 
the wild type exu protein. The decrease of the hyperphosphorylated form of transgenic 
exu protein (exu^s2.!) may result from a potential phosphorylation site on exu protein was 
removed in the exu^ ^^ -^  mutant. 
Although the effect of the ES2 mutation on exu is not significant during oogenesis. But it 
doesn't mean that the ES2 mutation is not significant during spermatogenesis. It is 
because the phosphorylation pattem (Cheung, 1997) and physiological function of the 
exu protein in ovary and testis are different (Hazelrigg et al., 1990). 
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The exu gene has been proven that it is essential for the Drosophila spermatogenesis 
(Hazelrigg et aL, 1990). In some of the exu mutants, functional sperm cannot be 
produced and they are male-sterile. The changing of the transgenic exu protein 
phosphorylation states may have changed the mutant (ES2.1) male fertility. 
Result ofthe rescue test showing that the ES2.1 mutant is not male-sterile. It is suggested 
that the males (ES2.1) can produced the functional sperm. But the transgenic exu protein 
may not be fully functional as for the phosphorylation of the protein (ES2.1) is changed. 
Compare number of the wild type progeny and the mutants (ES2.1) progeny is a simple 
‘ method to evaluate the male-fertility ofthe mutants (ES2.1). 
The male fertility crosses were setup and tested. The number ofprogenies obtained were 
accounted. The number of progenies showed a significant difference. It is suggested that 
the changing of phosphorylation state on the transgenic exu protein due to the ES2 
mutation affected the male-fertility, though the difference in the number ofprogeny is not 
very large. The possibility of the transgene chromosomal location effect should not be 
ignored as the wild type exu and the transgenic ES2 were located in the second and third 
chromosome, respectively. Therefore, another ES2 transgenic lines are needed in order 
to elimination this possibility. 
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CHAPTER 6 General Discussion 
The bcd mRNA localization at the anterior pole of Drosophila oocyte has been shown to 
be essential for the formation of embryo anteroposterior axis. The localization ofthe bcd 
mRNA is a complicated and tightly regulated process. The mRNA localization process 
can be divided into several steps. In the prelocalization step，the process dependent on 
exu protein. In the exu protein null mutant, bcd mRNA fails to be localized. The 
interactions between exu protein and bcd mRNA localization is either directly or 
indirectly. The controlling mechanism of exu protein acting on the bcd mRNA 
‘ localization is still unknown and it is very important for us to understand the body axis 
formation in Drosophila. 
Phosphorylation and localization of exu protein is stage-specific, and PKA is related to 
the exu protein localization (Cheung, 1997). At the previtellogeneic stage, the relative 
amount of hyperphosphorylated form of exu protein is greater than the 
hypophosphorylated form. In the vitellogeneic stage, the relative amount of the 
hyperphosphorylated form decreases, the relative amount ofprotein hyperphosphorylated 
form and hypophosphorylated form is nearly equal. After the vitellogeneic, the exu 
protein disappears. Moreover, the localization patterns of the exu proetin in oocyte 
during the oogenesis is also stage-specific. In PKA null mutants, the exu protein 
localization is affected during oogenesis. It is of interest to examine the relationship 
between the exu protein phosphorylation and its localization. 
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We hypothesize that phosphorylation controls the localization of exu protein and 
regulates the interaction between exu protein and bcd mRNA during early oogenesis. 
Phosphorylation may modulate the function of exu protein, and therefore alter the bcd 
mRNA localization. Role of the exu protein phosphorylation in oogenesis was studied 
through systematic deletion of potential phosphorylation sites by site-directed 
mutagenesis. 
Results of in vitro phosphorylation assay indicates that the ES2, ES3 and ES4 mutations 
did not affect the exogneous kinases phosphorylation on the exu proteins. The 
‘ phosphorylation patterns and levels of the transgenic exu proteins were similar to the 
wild type exu protein. However, it should be noted that conditions of phosphorylation 
may be different in vitro and in vivo. Excess exogenous kinases (PKA, PKC and PKG) 
were added to the in vitro phosphorylation reaction. The salts concentration and pH 
value of the in vitro phosphorylation buffer system may be different from the in vivo 
conditions. The exogenous kinases may non-specifically phosphorylated the transgenic 
exu protein in vitro. The non-specific phosphorylation was compensate the deduction of 
the transgenic exu protein phosphorylation caused by the ES mutations. Therefore, the 
effect ofthe ES mutations on the exu protein phosphorylation cannot be investigated. 
Result of the immunostaining experiment shows that the ES2 mutation did not affect the 
localization and the phosphorylation of the transgenic exu protein during oogenesis. In 
contrast, Westem blot analysis shows that the in vivo phosphorylation pattem of 
transgenic exu protein (ES2) from testis extracts was altered (Figure 5.7). These results 
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imply that the phosphorylation on the transgenic protein (ES2) are changed during 
spermatogenesis but not oogenesis. 
The functions and the phosphorylation pattem of the exu proteins are different 
during spermatogenesis and oogenesis. Different phosphorylation sites or kinase systems 
of exu protein may be used during oogenesis and spermatogenesis. Therefore, the 
phosphorylation patterns of the transgenic exu protein (ES2) in testis extracts may be 
different from that of the ovary extracts. The difference between the ovaries and testes 
extract can be further confirmed by isoelectric focusing (IEF). The different isoforms of 
• the exu protein in the ovaries and testes extracts can be separated by IEF. The different 
phosphorylated isoforms of the transgenic exu protein can be separated by IEF according 
to the pI values� 
The addition c-myc epitope is to distinguish the exogenous exu protein from the 
endogenous exu protein in the in vitro phosphorylation assay using the ovary or testis 
extracts kinase systems instead of the exogenous kinase system. Using anti-myc 
antibody, only the exogenous c-myc tagged exu protein was immunoprecipitated. The 
exogenous c-myc tagged exu protein was phosphorylated by the ovary extract in the 
presence of [^^P]-y-ATP. Then the c-myc tagged exu protein was immunoprecitpitated 
with the anti-myc antibody and separated by the SDS-PAGE. The phosphorylation ofthe 
c-myc tagged exu protein was directly visualized by auto-radiography. Unfortunately, no 
phosphorylated c-myc tagged exu protein was detected. This may be due to inefficient 
labeling of the c-myc tagged exu protein using the ovary extract kinase systems. In 
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addition, many phosphoproteins present in the ovary extract may serve as substrates of 
the ovary kinase systems, and this may explain for inefficiency. 
Although phosphorylation site deletions did not identify any change in in vitro 
phosphorylation patterns of ES2 mutated exu protein in the testes extract was observed. 
The in vitro phosphorylation experiment is a screening method in order to identify the 
putative phosphorylation sites. However, the in vitro assay has some limitations. 
Therefore, the transgenic in vivo assay on the ES1, ES3, ES4 and ES5 mutant constructs 
is necessary to determine whether mutation of phosphorylation sites had any effect on 
‘ oogenesis or spermatogenesis. 
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Appendix I: List of Regents 
Apple juice plate 
Agar (4.5g) was dissolved in 150ml double-distilled water. 5g of sucrose was dissolved 
in 50ml apple juice. Mix the agar solution and the sucrose solution. Add 1.5ml 20% 
Moldex into the solution. 
ATP (0.1 M) 
. ATP (O.lM) was made by dissolving 60mg of ATP (Sigma, disodium salt) in 0.8ml 
double-distilled water and the pH was adjusted to 7.0 with lN NaOH. The volume was 
adjusted to 1 ml and stored in aliquots at -70°C. 
BCIP 
BCIP (0.5g) (Sigma) was dissolved in 10ml of 100% dimethylformamide and the 
solution was stored at -20°C. 
EDTA (0.5 M) 
EDTA (18.61g) (BDH, disodium salt) was dissolved in 80ml double-distilled water and 
adjusted the pH to 8.0 with NaOH. The resulting solution was adjusted to 100ml and 
sterilized by autoclaving. 
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Electrode buffer (lOX) 
Tris base (30.3g) (USB) and 142.7g ofglycine (USB) were dissolved in 1000ml double-
distilled water. 
LB broth 
Bacto-tryptone (lOg), 5g of bacto-yeast extract and 10g of sodium chloride were 
dissolved in 950ml double-distilled water. Adjust the pH to 7.0 with 5N sodium 
hydroxide. Finally, adjust the volume to 1000ml with double-distilled water and sterile 
by autoclaving. 
LB agar plate 
Bacto-tryptone (lOg), 5g of bacto-yeast extract and 10g of sodium chloride were 
dissolved in 950ml double-distilled water. Adjust the pH to 7.0 with 5N sodium 
hydroxide. Finally, adjust the volume to 1000ml with double-distilled water. Add 15g of 
bacto-agar into the LB broth and then sterile by autoclaving. 
NBT 
NBT (0.5g) (Sigma) was dissolved in 10ml of 70% dimethylformamide and the solution 
was stored at -20°C. 
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PIPES (1.0 M) 
PIPES (30.24g) (FW 302.36) (BDH) was dissolved in 80 ml ofdouble-distilled water and 
the pH was adjusted to 6.8 with NaOH. (PIPES would gradually dissolved as pH 
increased.) The solution was adjusted to 100 ml. 
Proteinase inhibitors 
aprotinin (Sigma) - stock solution of lOmgAnl was made by dissolving in 0.01M 
HEPES 0)H 8.0) and stored at 4°C. 
leupeptin (Sigma)- stock solution of lOmgAnl was made by dissolving double-
distilled water and stored at 4°C. 
pepstatin A (Sigma)- stock solution of lmg/ml was made by dissolving in 
methanol and stored at 4°C. 
PMSF (Sigma)- Stock solution of 200mM was made by dissolving in ethanol and 
stored at 4°C. 
Transfer buffer 
Tris base (2.91g)，1.47g ofglycine，1.9ml 10 % SDS and 100 ml methanol were mixed 
and adjusted to 500 ml with double-distilled water. 
TBE (lOX) 
Tris base (54g), 27.5g of boric acid and 20ml 0.5M EDTA, pH 8.0 were mixed and 
adjusted to 1000ml with double-distilled water. 
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TY broth (2X) 
Bacto-tryptone (16g), 10g of bacto-yeast extract and 5g of sodium chloride were 
dissolved in 900ml double-distilled water. Adjust the pH to 7.0 with 5N sodium 
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